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Abstract  
 
Ischemic strokes occur when an occluded blood vessel limits the delivery of oxygen and 
nutrients to neurons, and can result in widespread cell death. Although stroke is the third leading 
cause of death and a major cause of disability among Canadians, the ability to treat this condition 
is limited, in part, due to an incomplete understanding of the underlying factors that influence 
cell death. The hippocampus, a structure intimately involved with learning and memory, is 
highly vulnerable to ischemic brain injury; however, evidence suggests that the various regions 
of the hippocampus do not respond homogenously to insult. In addition, previous work has 
shown that differences in response to injury also exist between male and female brain tissue. As 
a result, the present study aimed to investigate how various factors, including hippocampal 
region and sex, may influence variability in response ischemic insult. Acute hippocampal slices 
prepared from the septal and temporal poles of male and female Sprague-Dawley rats were 
subjected to an ex vivo model of stroke, oxygen-glucose deprivation (OGD). Cell viability 
assays, which measured mitochondrial function (2,3,5-triphenlytetrazolium chloride metabolism) 
and cell membrane integrity (lactate dehydrogenase release), were used to examine post-OGD 
slice viability. To better understand the role that the primary sex hormones, estrogen and 
testosterone, play in response to neuronal damage, tissue from rats at post-natal day 26-29 (pre-
adolescence) was compared to tissue from rats at post-natal day 61-64 (post-adolescence). The 
findings from this study suggest that hippocampal tissue harvested from the septal pole of male, 
pre-adolescent, rats displayed the greatest sensitivity to ischemic insult.  
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1.0 Literature Review 
1.1 Introduction to Ischemic Stroke 
 
Ischemic stroke is characterized by the reduction of cerebral blood flow, leading to an 
insufficient delivery of oxygen and nutrients to neurons (Heart and Stroke Foundation, 2015). 
Approximately 80% of all strokes are ischemic in nature, and have two main forms: global and 
focal (Columbia Neurosurgery, 2015; Heart and Stroke Foundation, 2015). Global ischemia is 
regarded as the reduction of blood flow to a wide range of neuronal tissue, whereas focal 
ischemia is restricted to a specific area of brain (Columbia Neurosurgery, 2015). With focal 
ischemia, the majority of damage is located within the ischemic core, a region of permanently 
infarcted tissue where blood flow is 10-25% of its normal perfusion rate (Internet Stroke Center, 
2015). Surrounding this area is a region of salvageable tissue, known as the ischemic penumbra. 
The loss of cerebral blood flow in the penumbra is less dramatic (25-50% of normal perfusion), 
thereby providing a greater chance of recovery from injury (Internet Stroke Center, 2015). Due 
to the delicate nature of brain tissue, the severity of ischemic injury is largely influenced by the 
duration of insult. Thus, if the ischemic insult persists over a sustained period of time, the 
ischemic core will expand into the penumbra and increase the extent of irreversible damage 
(Internet Stroke Center, 2015). 
In Canada, stroke is the third leading cause of death, and a major cause of disability. While 
more than 14 000 Canadians will die from a stroke each year, another 315 000 will suffer from 
its debilitating side effects (Heart and Stroke Foundation, 2015). Impairments in cognition, 
memory and motor coordination are common after-effects of stroke, and the Canadian economy 
is estimated to spend approximately 3.6 billion dollars annually in stroke related costs, including 
hospital and physician care (Heart and Stroke Foundation, 2015). Despite the severe socio-
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economic burden that stroke imposes, however, the ability to treat this condition remains limited, 
primarily due to an incomplete understanding of the underlying mechanisms driving stroke-
related cell death (Kostandy, 2012). 
1.2 Pathobiology of Ischemic Stroke   
Following ischemic stroke, a number of cellular pathways are activated, and contribute to 
neuronal toxicity (See Figure 1 for a schematic summarizing the pathophysiology of stroke). 
Initially, levels of oxygen and glucose within the brain are unable to meet the metabolic demands 
of brain tissue, which results in a depletion of ATP (Szydlowska and Tymianski, 2010; 
Kostandy, 2012).  Energy dependent processes, including function of the Na+/K+ ion pump, 
begin to fail, causing membrane depolarization.  With depolarization, there is a Ca2+-mediated 
release of glutamate, the primary CNS excitatory neurotransmitter, from pre-synaptic vesicles 
(Szydlowska and Tymianski, 2010; Kostandy, 2012).  Released glutamate acts upon three known 
ionotropic receptors; however, the two most related to cellular damage during ischemia are the α-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) and the N-methyl D-
aspartate receptor (NMDAR) (Szydlowska and Tymianski, 2010; Chang et al, 2012; Parsons and 
Raymond, 2014). 
Both AMPARs and NMDARs are tetrameric heteromers that play a role in mediating fast 
excitatory synaptic transmission (Michaelis, 1998; Traynelis, 2010).  While AMPARs are 
comprised of subunits GluA1-4 (Michaelis, 1998), NMDARs are composed of two obligatory 
GluN1 subunits, as well as two of six additional subunits, GluN2 (A-D) and GluN3 (A and B) 
(Michaelis, 1998; Traynelis, 2010). Under basal conditions, the majority of AMPARs contain the 
Ca2+-impermeable GluA2 subunit; a subset of receptors are, however, GluA2 lacking (Ca2+ 
permeable), and promote Ca2+-mediated signalling events (Traynelis, 2010; Blanco-Suarez and 
3 
 
Hanley, 2013). Also, at a resting membrane potential, the NMDAR channel is blocked by Mg2+ 
ions, which reduces Ca2+ permeability; however, following high frequency stimulation, the Mg2+ 
ion is expelled from the pore and Ca2+ influx into the post-synaptic cell is permitted (Traynelis, 
2010; Parsons and Raymond, 2014). 
During normal physiological conditions AMPARs and NMDARs mediate cognitive 
functions including learning and memory; however, following ischemia these receptors become 
overstimulated and initiate a number of negative cellular mechanisms that eventually trigger a 
phenomenon known as excitotoxicity (Nikonenko et al., 2009; Szydlowska and Tymianski., 
2010; Kostandy, 2012). Initially, glutamate induced excitotoxicity involves an influx of Ca2+ and 
Na+, which can indirectly damage neurons through the activation of certain cellular cascades. For 
example, excess Ca2+ will stimulate the production of reactive oxygen species (ROS) and 
nitrosylative species (RNS), which leads to free radical damage and mitochondrial dysfunction. 
Proteases, lipases and endonucleases are also activated, which can trigger the breakdown of 
cytoskeletal components and reduce cell membrane integrity. In addition, the activation of 
microglia can also cause damage through the release of cytotoxic molecules, including 
proinflammatory cytokines, which trigger an inflammatory response and eventually results in 
cell death (Kostandy, 2012).  The form of cell death undergone depends on the level of glutamate 
exposure and degree of neuronal insult experienced (Lipton and Nicotera, 2000; Szydlowska and 
Tymianski, 2010). Injured neurons located within the penumbra will often go through apoptotic 
cell death, in order to remove damaged tissue in a regulated manner (Lipton and Nicotera, 2000). 
In contrast, neurons located within the ischemic core may undergo a more immediate form of 
cell death, known as necrosis (Lipton and Nicotera, 2000).  Although the direct cellular 
mechanisms of Ca2+ -mediated excitotoxicity are incompletely understood, two theories are often 
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considered. The first is the “calcium-overload hypothesis,” which suggests that when 
concentrations of intracellular Ca2+ surpass a particular threshold, cytotoxicity is triggered 
(Szydlowska and Tymianski, 2010). A second theory, the “source specificity hypothesis,” argues 
that it is not the quantity of Ca2+, but the specific path of entry and second messenger pathways 
activated, which lead to neurodegeneration (Szydlowska and Tymianski, 2010).  
 Due to the detrimental outcomes associated with excitotoxicity, pharmacological 
therapies have targeted the glutamate system, specifically through the use of glutamate receptor 
antagonists, in order to evoke neuroprotection following ischemic stroke (Santangelo et al., 
2012). Unfortunately, nearly all of these treatments have failed during clinical trials due to a 
limited window of opportunity and suppression of the normal physiological functions of the 
glutamate receptors (Kalia et al., 2008). Despite attempts at designing glutamate-based 
neuroprotective therapies, the only current FDA approved treatment for stroke is a thrombolytic 
agent known as recombinant tissue type plasminogen activator (rtPa), which catalyzes the 
transformation of plasminogen into plasmin to promote fibrinolysis and restore blood flow 
(Montagne et al., 2012; Ali et al., 2014; Suzuki et al., 2016). However, the thrombolytic 
properties of this drug can also enhance the risk of intracranial bleeding through increasing 
permeability of the blood-brain barrier (BBB) (Suzuki et al., 2016). In addition, rtPa has been 
shown to modify NMDARs such that they display greater sensitivity towards excitotoxicity, 
potentially exacerbating ischemic damage in patients receiving treatment (Montagne et al., 2012; 
Suzuki et al., 2016). While most research in the field has focussed on the pharmacological 
treatment of stroke, more work surrounding its basic pathogenesis needs to be done in order to 
improve our understanding of this condition.  
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1.3 Ischemic Stroke and Regional Vulnerability 
1.3.1 Regional Vulnerability between Hippocampal Subfields  
 Global ischemia disrupts blood flow to a broad range of neuronal tissue; however, it is 
well recognized that certain areas of brain are more susceptible to ischemic injury than others. In 
1922, the term “pathoclisis” was coined to describe the selective vulnerability to pathological 
insult observed across anatomical regions (Vogt and Vogt, 1922). Based on the Vogt’s notion of 
pathoclisis, the hippocampus, a structure involved in the formation and consolidation of long-
term and spatial memory, is often given considerable attention (Schmidt-Kastner and Freund, 
1991; Grivas et al., 2003; Nikonenko et al., 2009; Nunez, 2012; Lalonde and Mielke, 2014). 
Located in the medial temporal lobe, the hippocampus is composed of varying subfields, 
including the cornu Ammonis 1 (CA1), cornu Ammonis 3 (CA3) and dentate gyrus (DG); 
however, even among these neuronal subpopulations there appears to be heterogeneity in 
susceptibility to cellular damage (Schmidt-Kaster and Hossman, 1988; Gee et al., 2006; Lalonde 
and Mielke, 2014). Previous animal studies have shown that, while the CA region, particularly 
CA1 pyramidal cells, are the most sensitive to brain injury, cells in the DG appear to be more 
robust (Akai and Yanagihara, 1993; Gee et al., 2006; Lalonde and Mielke, 2014).  
While the fundamental mechanisms for these differences remain unclear, one explanation 
may be differences in the function and distribution of glutamate receptors among hippocampal 
sub-fields. Gee et al. (2006) observed that, after global ischemia, CA1 pyramidal neurons 
underwent delayed cell death, coincident with tyrosine kinase activity that caused an 
upregulation in NMDAR responses. On the other hand, the CA3 region displayed a decrease in 
NMDAR function after cerebral ischemia, driven by protein phosphatase signalling. These 
findings suggest that neurons in possession of characteristics leading to a decrease in NMDAR 
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activity contribute to a more robust phenotype (Gee et al., 2006). Literature surrounding this 
topic remains controversial, however, as studies have also found there to be a decrease in the 
expression and functionality of the NMDARs in the CA1 region, but an increase in expression in 
the DG region (Zhang et al., 1997; Hsu et al., 1998). Similarly, research has also suggested that 
ischemia promotes selective AMPAR trafficking within the CA1 region; internalization of 
GluA2 subunits is followed by the insertion of Ca2+-permeable GluA2-lacking subunits onto the 
plasma membrane (Soundarapandian et al., 2005; Liu et al., 2006; Blanco-Suarez and Hanley, 
2013). Ultimately, increased Ca2+ permeability within CA1 pyramidal cells may account for their 
enhanced vulnerability to ischemic insult (Soundarapandian et al., 2005; Blanco-Suarez and 
Hanley, 2013).  
1.3.2 The Longitudinal Axis of the Hippocampus: Anatomical Differences 
 Apart from the functional differences that exist between hippocampal subfields, there is a 
growing body of literature to support the notion that notable differences are also present across 
the longitudinal axis of the hippocampus (Nadel et al., 1968; O’Keefe and Nadel, 1978; Ashton 
et al., 1989; Czerniawski et al., 2009; Fanselow and Dong, 2010; Isaeva et al., 2015; Strange et 
al., 2014; Bekiari et al., 2015). Although a distinct anatomical definition is not agreed upon, in 
general, the hippocampal long-axis is segmented into two poles, the septal pole (dorsal/posterior) 
and the temporal pole (ventral/anterior). The two poles are arbitrarily separated by an 
intermediate portion of tissue; however, intermediate hippocampal slices are thought to behave 
more like those obtained from the septal region (Strange et al., 2014; Maggio et al., 2015). See 
Figure 2 for a diagram of the longitudinal axis of the hippocampus.  
The idea that neuronal connectivity along the septo-temporal axis of the hippocampus is 
heterogeneous dates back as early as 1934 (Lorente de No). A recent review by Strange et al. 
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illustrates that projections from the cingulate cortex, a primary component of the limbic system, 
to the hippocampus, are distinct between the septal and temporal pole. For instance, the 
infralimbic and prelimbic cortices, involved in emotional processing, send input through the 
entorhinal cortex, the point of intersection between the neocortex and the hippocampus, to the 
temporal CA1 region. In contrast, the retrosplenial and anterior cingulate cortex, implicated in 
the regulation of visuospatial information and cognitive reasoning, project more septally within 
the CA1 (Fanselow & Dong, 2010; Strange et al., 2014). The lateral septum, a subcortical 
structure associated with reward and reinforcement, has also been shown to receive projections 
from the hippocampus in a graded fashion. Specifically, while the temporal CA1 and CA3 
subfields appear to project to more ventral regions of the lateral septum, the septal CA1 and CA3 
subfields send projections to more dorsal areas (Fanselow & Dong, 2010). Notably, the graded 
projections are maintained when travelling from the lateral septum to the hypothalamus; thus, 
output from the septo-temporal axis indirectly influences different areas of the hypothalamus 
responsible for autonomic and neuroendocrine related functions (Fanselow & Dong, 2010). 
Similarly, the nucleus accumbens and the amygdala, both structures involved in reward, decision 
making and emotional processing, also receive innervations from the hippocampus in a graded 
manner. In this case, output to the medial portion of both structures is received from the temporal 
pole of the hippocampus (Fanselow and Dong, 2010; Strange et al., 2014). Likewise, the ventral 
striatum (VS), implicated in the reward pathway, and the prefrontal cortex (PFC), which plays a 
role in decision making and executive function, receive projections solely from the temporal 
hippocampus (Bannerman et al. 1999; de Hoz et al., 2003). Furthermore, the temporal CA1 has 
also been found to directly innervate the olfactory bulb and related primary olfactory cortical 
structures (Fanselow and Dong, 2010).  
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1.3.3 The Longitudinal Axis of the Hippocampus: Functional Differences  
 While the distinct function of the hippocampus remains a topic of debate, differences in 
neural connections along the longitudinal axis are thought to be reflective of the functional 
differences observed between the septal and temporal poles. A study by Moser et al. (1995) 
examined the effects of hippocampal lesions, spanning across the longitudinal axis, on spatial 
navigation. In order to assess hippocampal-dependent spatial learning and memory, the Morris 
Water Maze (MWM), a widely accepted behavioural task performed by rodents, is often utilized 
(Morris, 1981). In this task, animals are initially placed into a large circular pool and must find 
their way to a hidden platform using visuospatial cues; the idea being that the lower the latency 
to escape the maze, the better their spatial memory. When lesions to the septal pole were greater 
than 40% of the entire hippocampus (60% of the hippocampi intact) impairments in task 
performance were observed; however lesions isolated to the temporal region did not impact 
spatial learning (Moser et al., 1995; Fanselow and Dong, 2010). These results suggest that the 
septal hippocampus is necessary for the induction of spatial navigation and memory. Moreover, 
performance does not appear to rely on a specific sub-section of the septal pole, all connections 
within this region are able to permit spatial learning (Moser et al., 1995). The role of the septal 
hippocampus in spatial cognition is thought to be due to a greater density of small, fine-tuned 
place cells, which are necessary for environmental navigation and episodic memory. In support 
of this theory, Jung et al. (1994) found that place cells located in the temporal hippocampus are 
larger and less fine-tuned than those located septally.   
 While the septal hippocampus appears to be important for cognitive behavioural tasks, 
evidence suggests that the temporal hippocampus is required for more emotion-based responses, 
including anxiety and unconditioned fear behaviour (Kjelstrup et al., 2002). In order to measure 
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levels of anxiety in animal models, a behavioural task known as the elevated plus maze is often 
used (Walf and Frye, 2007). The maze consists of two open and two enclosed arms, elevated 40-
70 cm off the floor, with rats originally placed in the center of the apparatus (Kjelstrup et al., 
2002; Walf and Frye, 2007).  Under normal circumstances, rats are initially reluctant to enter the 
open arms of the maze, due to their preference for dark enclosed spaces; however, Kjelstrup et 
al. (2002) found that lesions isolated to the temporal hippocampus reduced this anxiogenic 
behaviour, as rats entered the open arms more frequently. While the expression of 
unconditioned-fear responses was not influenced by lesions to the septal hippocampus, it 
appeared that contextual fear conditioning was associated with the septal pole (Kjelstrup et al., 
2002; Fanselow & Dong, 2010). Along with these findings, data from numerous studies support 
the argument that septally located hippocampal tissue, primarily in the CA1, is responsible for 
spatial/contextual memory, whereas temporal hippocampal tissue is involved in non-
spatial/innate emotional responses and affect (Nadel et al., 1968; Moser et al., 1995; Bannerman 
et al., 1999; Kjelstrup et al., 2002; Maren & Holt, 2004; Pothuizen et al., 2004; Rogers et al., 
2006; McEowen and Treit, 2009, 2010).  
The notion that the septal and temporal poles of the hippocampus are completely discrete 
in function is not universally accepted. A collection of data would argue that, although lesions to 
the hippocampus leaving the septal region intact permit spatial learning, the retrieval and 
retention of spatial memory involves networks within the temporal pole (de Hoz et  al., 2003, 
2014; Ferbinteanu et al., 2003; Louriero et al., 2011). When lesions to the hippocampus are given 
prior to any MWM training, only septally intact rats are able to learn the position of the platform; 
however, when lesions are given 1-2 days after the initial task training, spatial learning is only 
displayed in temporally intact rats (de Hoz et al., 2014). The role of the temporal hippocampus in 
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memory retrieval may be due to its distinct anatomical connections to the PFC and VS. When 
areas of the septal pole are damaged, associations between the PFC and VS may compensate by 
correlating visuospatial cues with reward and goal-oriented behaviour, thus leading to successful 
retention of memory (Louriero et al., 2011; de Hoz et al., 2014). Therefore, while the septal pole 
appears to play a greater role in spatial learning and memory, the evidence suggests that the 
temporal pole may also be important under certain circumstances.  
1.3.4 Response to Brain Injury across the Hippocampal Longitudinal Axis    
Despite extensive work concerning the structural and functional properties of the 
hippocampus, there is still an incomplete understanding regarding the variation that exists along 
the longitudinal axis. More specifically, the disparity between septal and temporal poles is often 
a concern in the context of brain injury, where vulnerability to cell death displays anatomical 
variation.  A selection of in vitro and in vivo studies have found that the temporal hippocampus 
shows greater susceptibility to epilepsy compared to the septal hippocampus, which may be 
attributable to a larger release of glutamate that promotes excitatory synaptic transmission 
(Racine et al., 1977; Lothman and Collins, 1981; Gilbert et al., 1985; Bragdon et al., 1986; Borck 
and Jefferys, 1999; Lee et al., 1990; Becker et al., 1997; Derchansky et al., 2004; 
Papatheodoropoulus et al., 2005). The release of glutamate from presynaptic terminals can be 
regulated by a number of different factors; one, in particular, being adenosine, via A1 receptors. 
The temporal CA1 region is known to contain significantly lower levels of A1 receptors; thus, 
the increase in epileptic activity is presumed to be caused by a higher glutamate-induced 
NMDAR response (Papatheodoropoulos et al., 2005).  
Furthermore, when assessing animal models of depression, the temporal pole displays 
greater neuronal impairments compared to the septal pole. Within the temporal region of the DG, 
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there is a profound loss of neuronal proliferation, presumably due to an unequal distribution of 
radial glial-like progenitor cells along the septo-temporal axis, which makes the septal pole more 
resilient to affective disorders (Tanti and Belzung, 2013; Bekiari et al., 2015).  In contrast, 
diseases involving neuro-inflammatory processes and de-myelination of axons, including 
multiple sclerosis, appear to negatively impact the septal hippocampus more readily than the 
temporal hippocampus, indicated by deficits in spatial and working memory (Bekiari et al., 
2015).  
Neuronal response to ischemic injury in the CA1 subfield also appears to follow a septo-
temporal gradient, with higher susceptibility to insult located septally (Smith et al., 1984; Ashton 
et al., 1989; Akai and Yanagihara, 1993; Rami et al., 1997; Maggio et al., 2015). Using 
histological methods to assess cell survival, Ashton et al. (1989) found that changes in 
coagulative cell morphology after ischemia increased from 10% to 90% from the temporal to 
septal pole, respectively. Electrophysiological data is also in agreement with this finding, 
whereby loss in synaptic transmission followed a similar gradient; slices from the temporal 
region displayed a 10% loss in field excitatory post synaptic potentials (fEPSP), while slices 
from the septal region showed a 70% loss (Ashton et al., 1989).     
 A previous study by Maggio and Segal (2007) indicated that the temporal hippocampus is 
less capable of producing tetanic LTP (tLTP), a marker of synaptic plasticity, when compared to 
the septal hippocampus. Similarly, recent evidence suggests that ischemic LTP (iLTP), a 
pathological phenomenon that occurs following ischemic insult, also varies across the 
longitudinal axis (Maggio et al., 2015). The expression of iLTP is greater within the septal pole 
compared to the temporal pole. The enhanced expression of iLTP was associated with a higher 
density of post-synaptic NMDARs, specifically containing GluN2A/B subunits, linked to 
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excitotoxicity, within the septal hippocampus (Maggio et al., 2015). Similarly, Pandis et al. 
(2006) also observed differences in the expression of glutamate receptor subunits between the 
septal and temporal poles. The mRNA levels of GluN2A and GluN2B subunits were greater 
within the CA1 and CA3, which corresponded to higher levels of subunit protein expression, 
within the septal pole compared to the temporal pole (Pandis et al., 2006). In addition, the overall 
level of AMPARs was lower in the temporal hippocampi compared to the septal hippocampi; 
thereby suggesting differences in functionality and excitatory transmission, which may explain 
the differences in response to brain injury observed across the septo-temporal axis (Pandis et al., 
2006). 
1.4 Sexual Dimorphism in Ischemic Stroke    
1.4.1 Epidemiology   
 Apart from the anatomical differences that exist in response to neuronal damage, 
emerging evidence now supports the claim that the occurrence of, and the susceptibility to, brain 
injury is also sexually dimorphic (Alkayed et al., 1998; Du et al., 2004; Li et al., 2005; Liu et al., 
2009; Cheng and Hurn, 2010; Manwani and McCullough, 2011). From an epidemiological 
perspective, the incidence of ischemic stroke is approximately 33% higher in men than in women 
(Scott et al., 2012). However, while men have a higher frequency of ischemic episodes across 
their lifespan, stroke-induced mortality is 45% greater in women (Manwani and McCullough, 
2011; Heart and Stroke Foundation, 2015).  
 There are particular stages throughout a woman’s life when she becomes more 
susceptible to stroke related injury, including pregnancy, childbirth, perimenopause (~45-55 
years old) and advanced age (>85 years old) (Scott et al., 2012). In addition, after menopause, 
the risk of stroke is higher in women than in men (Scott et al., 2012).  Since the age at which the 
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risk of stroke increases is higher in women (74.5) than in men (69.2), women often experience a 
greater number of co-morbidities and a lower functional outcome from stroke (Manwani and 
McCullough, 2011; Scott et al., 2012). The percentage of recurrent strokes is also greater in 
women; while 10% of men aged 45-64 experience a second stroke 5 years after their first 
ischemic episode, this value is doubled in age-matched women (Manwani and McCullough, 
2011). Furthermore, in men and women aged 65 years and older, the risk of a recurring stroke is 
20 and 25%, respectively, indicating that susceptibility to recurrent ischemic episodes is higher 
in women across various age sectors (Manwani and McCullough, 2011).   
1.4.2 Sexual Dimorphism in Experimental Models of Ischemia   
 Sex differences in both the incidence and recovery from ischemic brain injury have also 
been reproduced in animal studies (Carswell et al., 1999; Alkayed et al., 1998; Vagnerova et al., 
2008; Cheng and Hurn, 2010; Manwani and McCullough, 2011).  In vitro and in vivo models of 
ischemic insult propose that male brain tissue takes on an “ischemia sensitive” phenotype, 
whereas female brain tissue displays an “ischemia protective” phenotype (Cheng and Hurn, 
2010; Manwani and McCullough, 2011). Young (3-4 months) and middle aged (12-14 months) 
female rodents were less likely to develop spontaneous stroke lesions and displayed reduced 
vulnerability to neuronal damage following global and focal ischemia (Alkayed et al., 1998; 
Chung and Hurn, 2010; Manwani and McCullough, 2011). The trend was also displayed when 
rodents expressed co-morbidities including type 2 diabetes and hypertension (Carswell et al., 
1999; Cheng and Hurn, 2010). Differences in susceptibility to ischemic insult between male and 
female animals also persist with age. Liu et al. (2009) uncovered that aged female mice (16 
months) had increased tissue infarction compared to young female mice (9-12 weeks) following 
middle cerebral artery occlusion (MCAO; model of transient cerebral ischemia). However, aged 
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male mice displayed reduced levels of infarction relative to young male mice, despite having 
lower functional outcome and survival rates. These studies are in-line with what is observed 
clinically, whereby the risk of stroke is greater in women than in men, with age (Shapira et al., 
2002; Liu et al., 2009). While the biological mechanisms influencing these sex-based differences 
in response to neuronal damage are not well understood, differences in the primary sex 
hormones, estrogen and testosterone, are thought to play an important role.   
1.4.3 Estrogen as a Neuroprotectant 
  17β-Estradiol (estrogen) is a steroid hormone synthesized most readily in the female 
ovaries via the enzyme aromatase. Estrogen is able to travel through the bloodstream to act on 
effector tissues, including the brain, to initiate downstream cellular processes (Brann et al., 
2012). During the reproductive stages of life, serum levels of estrogen are high, particularly 
during the follicular phase of the menstrual cycle (analogous to the pro-estrous stage in rodents) 
(Nussy and Whitehead, 2001; Raval et al., 2009). However, following menopause, a decline in 
follicular tissue causes estrogen levels to decline considerably (Nussey and Whitehead, 2001). 
Changes in endogenous estrogen levels throughout the lifespan are suggested to contribute to the 
age related differences observed in vulnerability to ischemic brain injury (Etgen et al., 2011; 
Brann et al., 2012).         
 Numerous in vitro and in vivo studies have provided evidence to support the role of 
estrogen as a neuroprotectant (Alkayed et al., 1998; Toung et al., 1998; Wang et al., 1999; Miller 
et al., 2005; Li et al., 2005; Jover et al., 2002, 2007; De Butte-Smith et al., 2009; Gerstner et al., 
2009; Novotny et al., 2009; Etgen et al., 2011; Cai et al., 2014). Surgical removal of the ovaries 
in young, sexually mature, female rodents is a common procedure used to eradicate circulating 
levels of estrogen within the body. Ovariectomized (OVX) female rodents have been found to 
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suffer from greater cerebral infarction when compared to age matched gonadally-intact females 
(Alkayed et al., 1998). Removal of the ovaries also eliminated the sex-linked differences 
between male and female adults observed after ischemic insult (Alkayed et al., 1998). Consistent 
with these findings, Cai et al. (2014) reported that, following MCAO, female OVX adult mice 
displayed a 27.2% increase in infarct tissue and experienced higher cognitive impairments when 
compared to sham-control mice. Several laboratories have also revealed that both pre and post 
treatment with exogenous estrogen (25-300 μg) is capable of alleviating the neurodegenerative 
effects associated with brain ischemia, including CA1 pyramidal cell loss, infarct volume and 
functional outcome, in male and female adult rodents (Alkayed et al., 1998, 2000; Li et al., 2004; 
Miller et al., 2005; Plamondon et al., 2006; Gulinello et al., 2006 Cai et al., 2014; Li et al., 2011).  
 While the natural depletion of circulating estrogen levels associated with menopause is 
known to increase susceptibility to ischemic brain injury, work by Alkayed et al. (2000) has 
suggested that treatment with exogenous estrogen is able to reverse these effects in middle aged, 
reproductively inactive, female rats exposed to MCAO. Pre-treatment with estrogen for seven 
days decreased cerebral infarction by 16% in the cortex and 44% in the striatum (Alkayed et al., 
2000). Similarly, De Butte-Smith et al. (2009) demonstrated that, in middle aged female rats 
pretreated with estrogen, 50% of CA1 pyramidal cells survived global ischemia, compared to 
CA1 neurons from untreated animals. Data pertaining to both the removal and supplementation 
of estrogen in animal models at various stages of the lifespan support the notion that circulating 
levels of this primary sex hormone are important in protecting cells against cerebral damage and 
contribute to the “ischemia protective” phenotype displayed in women. 
1.4.4 Estrogen and Neurodegeneration  
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 In contrast to work characterizing estrogen as a neuroprotectant, several studies have 
found estrogen to exacerbate neuronal damage following brain injury (Harukuni et al., 2001; 
Bingham et al., 2005; Theodorsson and Theodorsson, 2005; Yong et al., 2005; Macrae and 
Carswell, 2006; Brann et al., 2012). Harukuni et al. (2001) observed that gonadally-intact adult 
female rats subjected to a 4 vessel-occlusion (4VO) model of ischemia displayed greater CA1 
pyramidal cell death in comparison to their OVX counterparts. However, the seemingly 
protective effects of reduced circulating levels of estrogen, seen in OVX animals, were 
diminished upon treatment with exogenous hormone, whereby the loss in CA1 cell survival was 
correlated with the dose of estrogen administered (Harukuni et al., 2001). Coinciding with these 
data, work by Theodorsson and Theodorsson (2005) showed that treatment with estrogen after 
MCAO increased cerebral infarction within the cortex and lateral striatum of adult female rats by 
approximately 82%. While these findings contradict studies showing a beneficial role of estrogen 
against neuronal damage, one explanation for the observed differences may be related to 
variability in the severity of ischemic injury endured. Presumably, with a greater duration of 
insult, there will be an expansion of the ischemic core; thus neuronal tissue will be more resistant 
to the neuroprotective effects of estrogen (Harukuni et al., 2001). In addition, it is possible that 
estrogen influences response to ischemia to a certain extent; however, once the degree of insult 
exceeds a particular threshold, the protective/detrimental effects of this hormone are no longer 
observed. This notion was demonstrated by Harukuni et al. (2001), wherein OVX and intact 
female rats that underwent 5 minutes of 4VO displayed differences in the percent of CA1 cell 
loss, but these differences were no longer present between groups following exposure to 10 
minutes of 4VO. 
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 Studies which test the dose-dependent effects of estrogen during brain injury are often 
conducted in adult OVX female animals. However, due to the aforementioned epidemiology of 
stroke, aged female animals may provide a more clinically relevant model to study the influence 
of reproductive senescence on susceptibility to ischemic damage in women after menopause (De 
Butte-Smith et al., 2009). While the loss of endogenous estrogen after menopause has been 
linked to an increased risk of cerebral ischemia, several studies have reported worse functional 
outcome and larger volumes of infarction in response to estrogen replacement therapy in aged 
animals (Wappler et al 2010; Strom et al., 2011; Leon et al., 2012). 
 The disparities in estrogen efficacy observed between young and aged animal models 
following neuronal damage may be due to variabilities in the dose of estrogen administered 
between studies. Such methodological differences bring into play the notion of hormesis, 
whereby sex hormones may exert a diverse range of functions at different concentrations (Strom 
et al., 2011). While physiological doses of estrogen (5-65 pg/mL) are thought to be associated 
with neuroprotection, supra-physiological doses (300-600 pg/mL) are affiliated with increased 
pro-inflammatory pathways and subsequent neurodegeneration (Strom et al., 2011). Despite this 
concept of hormesis, Cai et al. (2014) witnessed that in 22 month old female rats, both low and 
high doses of estrogen, 100 μg/mL and 300 μg/mL respectively, failed to improve neurological 
deficit scores following ischemia.   
 Numerous researchers have now suggested that there may be a “critical period” during 
which the effects of exogenous estrogen are protective against ischemic injury, and 
administration after this point may exacerbate cerebral damage (Brann et al., 2012; Scott et al., 
2012). In support of this theory, treatment with estrogen immediately following OVX was able to 
minimize neural impairments in the CA1 after global ischemic stroke. However if estrogen was 
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replaced 10 weeks after OVX, representing a period of long-term estrogen deprivation (LTED), 
typically associated with postmenopausal women, neuroprotection within the hippocampus was 
not observed (Suzuki et al., 2007; Zhang et al., 2009). While the mechanism remains unclear, it 
is known that LTED causes a decline in the estrogen receptor, ERα, which is associated with the 
hormone’s neuroprotective effects. Therefore, the lengthy period of estrogen deprivation may 
have prevented the receptor-mediated activation of beneficial cellular mechanisms, including 
programmed oxidative death pathways, such as ROS and NADPH oxidase (Zhang et al., 2009). 
Interestingly, despite the “critical period” hypothesis, a study by De Butte-Smith et al.  (2009) 
found that the time at which the ovaries were removed, relative to the time that estrogen was 
administered, did not have a significant effect on the neuroprotective actions of this hormone. 
When OVX occurred immediately, 1 week, or 8 weeks before chronic estrogen treatment 
(beginning 14 days before ischemic insult), neuronal survival rates were the same, indicating no 
negative effect of LTED on estrogen efficacy (De Butte-Smith et al., 2009). 
 Although the underlying cellular mechanisms responsible for the age-related 
discrepancies in vulnerability to ischemic insult are unknown, evidence suggests that glutamate-
induced NMDAR activation may play a distinct role (McEwen, 1996; Gazzaniga et al., 2004). 
Previous evidence suggests that estrogen plays a role in the regulation of dendritic spine density, 
NMDAR binding, LTP and LTD within the hippocampal CA1 (Hart et al., 2001). In addition, 
treatment with estrogen is thought to cause GluN1 subunit upregulation on dendrites and cell 
bodies within the CA1 via post-translational modifications (PTMs), specifically through 
muscarinic-cholinergic transmission (Gazzaniga et al., 2004). Within young female rats, the 
increase in GluN1 subunit expression is accompanied by an increase in the production of 
dendritic spines, so that the GluN1-dendritic spine ratio is equal. However in aged female rats, 
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the increase in GluN1 subunit density is not accompanied by an upregulation of dendritic spines; 
thus potentially explaining the greater susceptibility to excitotoxic related ischemic injury 
(Gazzaniga et al., 2004).  Interestingly, work by Hart et al. (2001), using double-label 
immunohistochemistry, revealed that the expression of estrogen receptors associated with 
neuroprotection are differentially distributed across the longitudinal axis of the hippocampus. 
While the septal hippocampus displayed a higher expression of ERα-positive cells within 
GABAergic neurons (primary inhibitory neurotransmitter), the temporal hippocampus displayed 
greater expression of ERα within pyramidal cells, thereby theoretically leading to differences in 
response to estrogen across the hippocampal long axis (Hart et al., 2001).   
1.4.5 Testosterone and Ischemic Injury  
 When examining the sex-linked disparities associated with the onset and recovery from 
ischemic insult, the potential role that male androgens play is often less considered. However, 
given that, for the majority of the lifespan, the incidence of stroke is higher in men compared to 
women, it seems necessary to explore the influence of testosterone on brain injury.  
 Testosterone is a steroid hormone produced in the testicles of male animals and, to a 
lesser degree, the ovaries of female animals (Mooradian et al., 1987). Circulating levels of 
testosterone are approximately 8 times higher in male animals, however, making it their primary 
sex hormone (Mooradian et al., 1987; Torjesen et al., 2004). Although the majority of research 
focusses on the neuroprotective effects of estrogen following brain ischemia, a branch of the 
literature suggests that sexual disparities observed during ischemic injury are, instead, associated 
with the lethal effects of testosterone (Cheng and Hurn, 2010). There is a natural decline in the 
plasma concentration of testosterone attributable to ageing; over time reductions in the level of 
this hormone may be responsible for the lower risk of stroke found in ageing men, as compared 
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to women (Cheng and Hurn, 2010). Both clinical and experimental models have displayed a 
drastic reduction in serum levels of testosterone following stroke, and this stress-induced decline 
in testosterone could serve as an initial mechanism to protect against ischemic injury (Yang et 
al., 2002; Cheng and Hurn, 2010).  
 High levels of testosterone have been shown to significantly increase glutamate-induced 
neurotoxicity in vitro. Administration of 10 μM testosterone to HT-22 cells was shown to 
escalate cell death from 71.9% to 87.5% (Yang et al., 2002). In addition, primary rat 
oligodendrocytes treated with 100 nM testosterone displayed augmented cellular damage caused 
by the over-activation of AMPA and kainate receptors (Caruso et al., 2004). In agreement with 
these data, in vivo studies have revealed that castrated male rodents given testosterone display 
greater ischemic lesion sizes than their un-treated counterparts (Hawk et al., 1998).  At the same 
time, however, low levels of testosterone have also been affiliated with greater susceptibility to 
cerebrovascular accidents and worsened functional outcome (Jeppesen et al., 1996; Yeap et al., 
2009; Cheng and Hurn, 2010; Fanaei et al., 2014). Similarly, treatment with concentrations of 
testosterone ranging from 1 nm to 1 μM also seems to protect neurons against toxicity in vitro 
(Ahlborn et al., 2001; Nguyen et al., 2005, 2007).  
 While the shift from the beneficial to detrimental effects of testosterone following brain 
injury are not completely understood, the role of this androgen appears to follow a dose-
dependent gradient (Cheng and Hurn, 2010). Uchida et al. (2009) observed that while low 
physiological levels of testosterone (1.5 mg) prior to MCAO reduced tissue infarction from 37% 
to 26% in castrated male mice, treatment with higher doses (5 mg) amplified infarct volume to 
53%. Physiologically relevant doses of testosterone (5-25 mg) may upregulate pro-inflammatory 
gene expression following MCAO, and account for the neuro-damaging effects of this androgen; 
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however, more research is required to unveil the underlying biological mechanisms driving 
testosterone-related neuroprotection and neurodegeneration after ischemic insult (Bhasin et al., 
2001; Uchida et al., 2009). 
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2.0 Study Rationale 
 Extensive work concerning how to treat ischemic stroke has been completed, with few 
successful developments (Montagne et al., 2012; Lopez-Valdes et al., 2014; Kafi et al., 2014). 
Previous literature has often focussed on methods of pharmacotherapy without full consideration 
of the distinct anatomical and physiological differences that exist among stroke patients. As a 
result, more research needs to be completed to better understand the underlying biological 
characteristics that contribute to variation in the brain’s response to injury.  
 Recent work surrounding anatomical differences in response to brain injury have shown 
variation across the longitudinal axis of the hippocampus. Both histological and 
electrophysiological data suggest that tissue harvested from the septal pole is more susceptible to 
ischemic insult when compared to tissue located temporally (Ashton et al. 1989; Maggio et al., 
2015) Considering these findings, this  research aims to contribute to the literature concerning 
septo-temporal disparities, and hopes to confirm previous findings regarding  selective 
vulnerability along the hippocampal long axis by using distinct measures of cell viability, 
including mitochondrial metabolism and cell membrane permeability. 
 In addition, although the influence which biological sex has on vulnerability to cerebral 
ischemia remains unclear, sex hormones clearly play a marked role (Jeppesen et al., 1996; 
Alkayed et al., 1998; Toung et al., 1998; Wang et al., 1999; Harukuni et al., 2001; Jover et al., 
2002; Bingham et al., 2005; Jover et al., 2005; Li et al., 2005; Miller et al., 2005; Theodorsson 
and Theodorsson, 2005; Yong et al., 2005; Macrae and Carswell, 2006; De Butte-Smith et al., 
2009; Gerstner et al., 2009; Novotny et al., 2009; Yeap et al., 2009; Etgen et al., 2011; Brann et 
al., 2012; Cai et al., 2014; Fanaei et al., 2014). Better understanding the functional role played by 
estrogen and testosterone in brain injury, as well as the basic molecular mechanisms driving 
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these processes, is crucial to the development of clinical treatments for stroke-related brain 
damage. Therefore, the proposed research also hopes to contribute to our current knowledge by 
exploring the potential sexual dimorphism that exists along the septo-temporal axis of the 
hippocampus following ischemic stroke.  
I expected to meet the following objectives: 
1.  Determine how oxygen-glucose deprivation (OGD; an ex vivo model of ischemia) 
differentially influences cellular viability in slices acutely prepared from the septal and 
temporal poles by measuring mitochondrial metabolism, cell membrane integrity and 
proteolytic calpain activity. 2,3,5-triphenyltetrazolium chloride (TTC) metabolism was 
used to evaluate mitochondrial function, whereas a lactate dehydrogenase (LDH) release 
assay was employed to assess membrane permeability. In addition, the assessment of 
spectrin breakdown products (SBDPs), via Western blot analysis, was used to examine 
calpain activity and necrotic cell death.  
2. Determine potential sex-linked differences in susceptibility to ischemic injury along the 
septo-temporal axis of the hippocampus, as well as the possible contributing role of sex-
hormones. Age was used as a means to naturally study the concentration of circulating 
hormone levels; while pre-adolescent male and female rats were expected to share equal 
concentrations of both hormones, following adolescence male and female rats contained 
higher levels of testosterone and estrogen, respectively.    
3. Determine potential differences in response to ischemic injury between pre-adolescent 
and post-adolescent stages of life, in male and female rats.   
 Based on the current literature, I hypothesized that acute hippocampal slices taken from 
the septal pole would exhibit greater levels of tissue damage compared to slices obtained from 
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the temporal pole, as indicated by impaired mitochondrial function and compromised membrane 
integrity. Due to the apparent sexual dimorphism that exists within the brain following injury, I 
also proposed that hippocampal slices extracted from pre-adolescent male and female animals 
would show no sex-based differences in response to OGD. However, tissue harvested from 
sexually mature female rats was expected to display greater resilience to OGD compared to 
tissue from male animals. Lastly, I proposed that the expression of SBDPs would be greater 
within septal hippocampal slices relative to temporal hippocampal slices, indicative of their 
respective cell death profiles.   
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3.0 Materials and Methods 
 
3.1 Animals 
 All experiments were conducted on male and female Sprague-Dawley rats, following 
procedures approved by the animal care committee at the University of Waterloo. All animals 
were group housed and maintained under a 12 h reverse-light cycle (8:00 a.m. to 8:00 p.m.) with 
access to food and water ad libitum.     
3.2 Acute Hippocampal Slice Preparation  
 Experiments were conducted using acute hippocampal slices prepared from male and 
female rats at either postnatal day (PND) 26-29 (representing pre-adolescence), or PND 61-64 
(representing young adulthood) (See Figure 3 for a summary of experimental protocol.) 
 Rats were anesthetized with CO2 and sacrificed via decapitation. Brains were removed 
(~60 s) and placed in chilled (<4°C) artificial cerebral spinal fluid (ACSF) composed of (in 
mM): 124.0 NaCl, 3.0 KCl, 1.2 NaH2PO4/H2O, 1.0 MgSO4/7H2O, 2.0 CaCl2/2H2O, 26.0 
NaHCO3, 10.0 Glucose and 10.0 HEPES buffer, equilibrated with carbogen (95% O2/5% CO2), at 
pH 7.37-7.43, 310-320 mOsm (these and all remaining reagents were purchased from Sigma 
Aldrich Canada Co. unless stated otherwise). Both right and left hippocampi were removed from 
their respective hemispheres and positioned onto the platform of a McIlwain tissue chopper 
(Mickle Laboratory Engineering Co., Surrey, UK) with the septal pole facing the blade. Slices 
(350 μm) were prepared in the following manner: the first 4 slices were considered part of the 
septal region, while the last four slices were considered part of the temporal region. Tissue 
between these two poles (generally 4-8 slices) were considered part of the intermediate region 
and discarded. Septal and temporal slices were then positioned on cell-culture inserts (2 slices 
per insert) placed on either a mesh platform for the TTC assay, or in Petri dishes filled with 1 mL 
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of ACSF for the LDH assay. All slices were held at interface in an incubation chamber, 
continuously perfused with carbogenated ACSF at 35°C ± 0.5°C for a recovery period of 
approximately 60 minutes. 
3.3 Oxygen-Glucose Deprivation 
 A subset of septal and temporal slices were subject to ten minutes of OGD. Inserts were 
transferred to a mesh platform in a second incubation chamber containing modified ACSF, 
wherein glucose was substituted for sucrose, and that was continuously perfused with N2 gas at 
35°C ± 0.5°C. Control slices underwent a SHAM procedure to account for any stress 
experienced during movement. Following OGD, ACSF in all Petri dishes was replaced with 1 
mL of fresh carbogenated ACSF, and inserts were returned to their original incubation chamber 
to initiate a 3 hour recovery period.    
3.4 2,3,5-Triphenyltetrazolium Chloride (TTC) Assay 
 Septal and temporal slices from SHAM and OGD treatment groups were transferred to 
glass scintillation vials (2 slices per vial) containing 2% (w/v) TTC solution; 2,3,5- TTC powder 
was prepared with ACSF and saturated with N2 for 5 minutes. All vials were covered in foil, to 
prevent light reaction, and were incubated for 60 minutes at 35°C ± 0.5°C. Following incubation, 
slices were rinsed twice with aerated ACSF and submerged in 1.5 mL extraction buffer (DMSO 
and 95% EtOH prepared 1:1) overnight (~18-24 h) in the dark at room temperature. Average 
formazan absorbance was measured at 485 nm using a spectrophotometer.   
3.5 Lactate Dehydrogenase (LDH) Release Assay  
 LDH release from septal and temporal slices was measured using an LDH Cytotoxicity 
Assay Kit (Cayman Chemical; Michigan, USA). Following a 3 hour recovery period, 100 µL 
aliquots of ACSF in Petri dishes from each treatment condition were loaded, in triplicate, onto a 
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96-well plate; 100 µL of LDH reaction solution was then added to each well. Plates were 
incubated in an orbital shaker, with gentle shaking, at 37°C for 30 minutes. Average LDH 
absorbance was measured at 490 nm via spectrophotometry.  
3.6 Vaginal Cytology 
 Estrus cycle staging in sexually mature female rats was done through the assessment of 
wet vaginal smears using a protocol adopted by Hubscher et al. (2005). Following decapitation, 
200 µL of 1X PBS was inserted into the rat’s vagina, using a 200 µL pipette tip, and immediately 
drawn back up. The sample was released onto a clean glass microscope slide and a coverslip was 
placed on top. Cells in the vaginal epithelium were then examined under a light microscope at 
40x magnification to qualitatively determine the stage of the estrus cycle. Proestrus, the stage in 
which estrogen levels are greatest, was characterized by the presence of densely packed 
nucleated epithelial cells. In contrast, estrus (ovulation) was distinguished by the presence of 
cornified epithelial cells, which predominated among other cell types. During the final two 
stages of the cycle, where estrogen levels are lowest, diestrus was discerned by a large number of 
leukocytes, which were often surrounded by nucleated epithelial cells, while metestrus contained 
dispersed populations of leukocytes, in addition to both nucleated and cornified epithelial cells 
(Long and Evans, 1922; Mandl, 1951; Marcondes et al., 2002) (See Figure 4 for a representative 
image of each stage of the estrus cycle.)     
3.7 Blood Serum Collection 
 Immediately following the decapitation of post-adolescent female rats, trunk blood was 
collected, using a 5 mL syringe, and subsequently dispensed into two 1.5 mL microcentrifuge 
tubes. Blood was allowed a 30 minute period of coagulation, followed by 15 minutes of 
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centrifugation at 2000 x g and 4°C. The resultant supernatants (blood serum) were then stored at 
-80°C for potential future analysis of serum estrogen levels.     
3.8 Tissue Homogenization 
 In some experiments, following a 10 minute SHAM/OGD challenge, septal and temporal 
slices prepared from the left hippocampus were mechanically homogenized in 400-500 µL of 
non-ionizing lysis buffer (100 mM NaCl, 25 mM EDTA, 10 mM Tris, 1% (v/v) Triton X-100, 
1% (v/v) NP-40) supplemented with a protease inhibitor cocktail (AEBSF, Aprotinin, Bestatin 
hydrochloride, E-64, Leupeptin hemisulfate salt, Pepstatin A) and sodium orthovanadate. 
Homogenates were centrifuged for 10 minutes at 1000 x g and the supernatants were stored at     
-80°C for later analysis using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE). Prior to storage, the protein concentration of each hippocampal slice homogenate was 
determined using a BioRad DC protein assay kit; the optical density of each unknown sample 
was compared to  bovine serum albumin (BSA), which was used as a protein standard.  
3.9 SDS-Page and Immunoblotting  
Frozen hippocampal homogenates were thawed and loaded in duplicate (5 µg 
protein/lane) for SDS-PAGE. Proteins were then blotted onto polyvinylidene fluoride (PVDF) 
membranes using a wet transfer technique (35 V at 4°C overnight). Ponceau S solution was used 
to confirm a successful protein transfer; membranes were then blocked with 5% skim milk 
powder (w/v) made in TBS-T [20 mM Tris 140 mM NaCl, 01% Tween-20 (v/v), pH 7.6] for 1 
hour at room temperature.  
Immunoblotting was performed to probe for biomarkers of necrotic cell death, SBDPs, 
using the primary antibody, spectrin α II (C-3) (1:1000, mouse monoclonal IgG1, #sc-48382; 
Santa Cruz Biotechnology, USA). All blots were incubated with the primary antibody overnight 
29 
 
at 4°C, and then incubated with an HRP-linked anti-mouse secondary antibody (1:5000) for 1 
hour. All solutions were prepared in a 5% (w/v) skim milk/TBS-T blocking buffer and secondary 
antibodies were activated via incubation with enhanced chemiluminescence (ECL) substrate. In 
order to detect the density of each band, SYNGENE was used with exposure intervals ranging 
from 30 seconds to 3 minutes (all analyzed points were selected from within the linear range of 
detection). 
3.10 Exclusion Criteria  
 Based on an a priori criterion that slices exposed to OGD would endure greater cellular 
damage than SHAM treated slices, data points were removed if TTC metabolism in OGD slices 
was equal to, or higher than, SHAM treated slices; out of a total of 80 animals, nine animals 
were removed from the final data analysis for violation of the a priori criterion (Table 1). 
Likewise data points were removed if LDH efflux in OGD slices were equal to, or lower than, 
SHAM treated slices. Notably, in those cases where a data point was excluded, data points from 
the opposite pole were also removed.  
3.11 Statistical Analysis  
 All data were stored in Microsoft Excel worksheets. To examine the influence of the 
primary sex hormones on response to ischemic injury, SHAM and OGD hippocampal slices 
obtained from the septal and temporal regions were compared between and within sexes in both 
pre-adolescent and post-adolescent groups. Differences between groups were assessed through 
either the calculation of difference scores (mean of group 1 – mean of group 2; 𝜇̅1 - 𝜇̅2) followed 
by the Wilcoxon signed-ranked test (one-sample test), or through the Mann-Whitney U test (two-
sample test), both of which are non-parametric statistical tests that do not assume the data are 
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normally distributed. All calculations were done using GraphPad Prism 7 and statistical 
significance was set at p ≤ 0.05.  
 The effect size index, using Cohen’s d (standardised mean difference), as well as 95% 
confidence intervals (CIs) were calculated using the Exploratory Software for Confidence 
Intervals (ESCI) program. Interpretation of biological relevance was guided by Cohen’s 
conventions: Cohen’s d = 0.2 (small magnitude of effect), d = 0.5 (moderate magnitude of 
effect) and d = 0.8 (large magnitude of effect) (see Nakagawa and Cuthill, 2007 for more 
information on effect size). The statistical significance (p value) and the magnitude of effect (d 
value), along with its 95% CI, were considered together in order to make inferences about the 
data collected.      
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4.0 Results 
 
4.1 Lactate Dehydrogenase (LDH) Release Assay Data Analysis 
 
4.1.1 Changes in LDH Release could not be Detected Following OGD  
The amount of LDH released from hippocampal slices was intended to be used as an 
indication of damage to the cell membrane (see materials and methods section 3.5). Although 
basal levels of LDH release were detected from slices across the longitudinal axis, no statistically 
significant difference in LDH efflux was observed between SHAM treated slices and slices 
subjected to 10 minutes of OGD within male septal (p = 0.22), male temporal (p > 0.99), female 
septal (p = 0.15), or female temporal (p = 0.22) pre-adolescent rats (all LDH data collected from 
cohort 1) (Figure 5). Calculation of Cohen’s d also revealed no effect of a 10 minute OGD 
challenge on changes in LDH release within pre-adolescent male septal (d = 0.49) or male 
temporal (d = 0.08) slices; despite a large effect size calculated in the female septal (d =0.84) 
and female temporal (d = 1.1) group, the direction of effect was opposite to that which would 
have been expected, as SHAM slices displayed greater LDH efflux than OGD slices. 
Within post-adolescent rats, the concentration of LDH released into the surrounding 
ACSF was not statistically significantly different between SHAM and OGD slices from the male 
septal (p = 0.10), male temporal (p = 0.22), female septal (p = 0.15), or female temporal (p = 
0.84) groups. Calculation of Cohen’s d also confirmed no effect of OGD within the female 
temporal group (d = 0.18), but suggested an effect within post-adolescent male septal (d =1.44), 
male temporal (d =0.71), and female septal (d =1.17) slices. Despite these values, however, the 
direction of effect was opposite to that expected, as SHAM slices displayed greater LDH efflux 
than OGD slices (Figure 6).     
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In order to determine whether the failure to detect an increase in LDH concentration was 
due to an insufficient degree of injury, a subset of slices taken from pre-adolescent male rats was 
subjected to 30 minutes of OGD and a 3 hour recovery period. Two slices were also submerged 
in a vial containing 1 mL of ACSF (previously saturated with carbogen) and were kept at 35°C ± 
0.5°C for 4 hours, to serve as a positive control of LDH efflux. Similar to the results obtained 
following 10 minutes of insult, 30 minutes of OGD did not cause appreciable changes in LDH 
release compared to SHAM slices. In contrast, a considerable increase in LDH release was 
detected in the positive control group (Figure 7). Since the values observed following both 10 
and 30 minutes of ischemia violated an a priori assumption, which states that slices treated with 
OGD should have higher LDH efflux than SHAM slices, a decision was made to eliminate the 
LDH assay as a measure of cellular viability during the second cohort. 
 
4.2 2,3,5-Triphenyltetrazolium Chloride (TTC) Assay Data Analysis  
4.2.1 Ten Minutes of OGD Reduces TTC Metabolism in Hippocampal Slices  
To confirm that 10 minutes of OGD (see materials and methods section 3.3) was 
sufficient as a model of injury in acute hippocampal slices, in preliminary work, the average 
formazan absorbance was quantified in a subset of male (~PND 60) SHAM and OGD slices 
taken from across the longitudinal axis (outlined in materials and methods section 3.4). Ten 
minutes of OGD successfully reduced TTC metabolism relative to SHAM treatment in septal (p 
= 0.03) and temporal (p = 0.0079) slices. Calculation of Cohen’s d also confirmed that OGD had 
a large effect on mean formazan absorbance in septal (d = 2.01; 95% CI = 0.40, 3.54) and 
temporal (d = 1.86; 95% CI = 0.29, 3.35) slices (Figure 8).  
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4.2.2 Response to OGD across the Hippocampal Longitudinal Axis   
In order to assess whether 10 minutes of OGD differentially influenced mitochondrial 
metabolism across the longitudinal axis, average formazan absorbance in septal and temporal 
slices was quantified. Injured slices from both poles were taken as a % of the respective SHAM 
slices in pre and post-adolescent animals and difference scores were constructed for each 
experimental group (Table 2). No significant differences in TTC metabolism were observed 
between septal and temporal slices taken from male pre-adolescent (p = 0.20, d = 0.55), female 
pre-adolescent (p = 0.43, d = 0.39), male post-adolescent (p = 0.19, d = 0.47), or female post-
adolescent (p = 0.49, d = 0.23) rats (Figure 9). 
4.2.3 Sex-Linked Differences in Response to OGD  
To examine the potential influence of exposure to varying levels of the primary sex 
hormones, estrogen and testosterone, following 10 minutes of OGD, % of SHAM difference 
scores were constructed between pre-adolescent male and female (N = 9) and post-adolescent 
male and female (N = 10) rats, in slices from across the longitudinal axis (Table 3). Within the 
septal pole of the hippocampus, sex had a large effect (d = 0.90) on response to insult between 
pre-adolescent animals, whereby TTC metabolism in male septal slices was lower than TTC 
metabolism in female septal slices. Sex also appeared to have a large effect (d = 0.89) on TTC 
metabolism within the temporal pole, with pre-adolescent female rats displaying greater 
sensitivity to injury than pre-adolescent male rats; however, this difference did not reach 
statistical significance (p = 0.07). No significant differences in response to OGD were observed 
between male and female animals during post-adolescence in both septal (p = 0.63, d = 0.02) 
and temporal slices (p = 0.63, d = 0.05) (Figure 10). 
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4.2.4 Age Related Differences in Response to OGD 
To determine whether mitochondrial metabolism following 10 minutes of OGD differed 
between animals at various stages of brain development, % of SHAM difference scores were 
constructed between pre and post-adolescent male (N = 9) and female (N = 10) animals (Table 
4). Within the septal pole of the hippocampus, TTC metabolism was lower in pre-adolescent 
male slices to a statistically significant degree (p = 0.05) relative to post-adolescent male slices. 
Further confirmation with Cohen’s d effect size revealed a moderate to large effect of age on 
response to injury (d = 0.68). However, no significant differences in TTC metabolism were 
observed between pre and post adolescent male temporal slices (p = 0.57, d = 0.26). Likewise, 
there were no significant differences in TTC metabolism present between pre and post-
adolescent female septal (p = 0.77, d = 0.17) or temporal (p = 0.85, d = 0.03) slices (Figure 11). 
4.3 Estrus Cycle Staging and Circulating Levels of Estrogen   
4.3.1 Estrogen Levels and Response to OGD across the Longitudinal Axis 
In order to account for potential differences in response to OGD caused by varying levels 
of circulating estrogen, estrus cycle staging was performed on sexually mature female rats (N = 
20) (materials and methods section 3.6). For a number of reasons (violation of an a priori 
assumption, experimental error, estrus cycle could not be discerned) N = 7 rats were excluded 
from the analysis, and the remaining N = 13 rats were stratified based on their respective stage of 
the estrus cycle.  
To assess how levels of estrogen may influence response to injury across the longitudinal 
axis, rats were further categorized into high estrogen (proestrus; N = 5) and low estrogen (estrus, 
metestrus and diestrus; N = 8) groups; % of SHAM difference scores were then calculated 
between septal and temporal slices for each group (Table 5). High levels of circulating estrogen 
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did not have an apparent effect (d = 0.12) on TTC metabolism across the longitudinal axis, as 
septal and temporal slices were not different to a statistically significant degree (p = >0.99). 
Similarly, in animals with low levels of circulating estrogen, no statistically significant 
differences (p = 0.31) in TTC metabolism were present between septal and temporal slices, 
which was further confirmed by a small Cohen’s d effect size (d = 0.35) (Figure 12). 
4.3.2 Estrogen-Concentration Dependent Differences in Response to OGD  
To better understand how fluctuating levels of estrogen may differentially influence 
response to OGD in post-adolescent female animals, mean % SHAM TTC values were compared 
between high (N = 5) and low (N = 8) estrogen level groups (Table 6). Although calculation of 
Cohen’s d suggested a moderate to large effect of estrogen level on response to injury in both the 
septal (d = 0.78) and temporal (0.14) poles, these values did not reach statistical significance 
(septal: p = 0.35; temporal: p = 0.72). Further assessment of the 95% CIs revealed values 
containing 0; thereby further implying no statistically significant differences between the groups 
(Figure 13).  
4.4 SDS Page and Immunoblotting  
4.4.1 Optimal Protein Concentration for Immunoblotting 
 In order to determine the optimal protein concentration that would generate a clear signal 
without saturation, the αII-spectrin antibody was probed against hippocampal tissue over a series 
of various protein concentrations ranging from 2.5 μg – 15 μg.  (See Figure 14 for a standard 
curve optimization blot conducted with post-adolescent male septal SHAM tissue.) Based on the 
results, 5 μg was determined to be the optimal sample loading concentration. 
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4.4.2 Preliminary Assessment of SBDP Expression across the Longitudinal Axis    
 To confirm whether 10 minutes of OGD would trigger calpain mediated cleavage of the 
280 kDa αII-spectrin protein, indicative of necrotic cell death (Knox et al., 2013), protein 
expression of 150 kDa SBDPs were measured in homogenates prepared from SHAM and OGD 
slices across the hippocampal longitudinal axis using Western blot analysis. The assessment of 
homogenates is ongoing. (See Figure 15 for a representative blot of SBDP expression within 
pre-adolescent male tissue.)   
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5.0 Discussion 
 
While the majority of research often considers the hippocampus a homogeneous 
structure, a growing body of literature has proposed that differences in response to brain injury 
are present across the hippocampal longitudinal axis (Lorente de No., 1934; Smith et al., 1984; 
Ashton et al., 1989; Akai and Yanagihara, 1993; Rami et al., 1997; Maggio et al., 2015). In an 
effort to address this possibility, I examined how basic factors, including sex and age, 
contributed to differences in response to ischemic insult across the longitudinal axis. Cell 
viability following 10 minutes of OGD was analyzed in septal and temporal hippocampal slices 
isolated from male and female rats during either the pre-adolescent or post-adolescent stages of 
life.   
5.1 Lactate Dehydrogenase Release Assay 
 
5.1.1 Increased LDH Release could not be detected following OGD 
 
Lactate dehydrogenase (LDH) is a soluble enzyme present in the cytoplasm of almost all 
cells (Izumi et al., 2001). Following ischemic stroke, the plasma membrane integrity of neurons 
is compromised, which results in higher amounts of LDH release into the surrounding 
cerebrospinal fluid (CSF) (Lampl et al., 1990). Based on this phenomenon, LDH release has 
become a useful measure of cytotoxicity (Koh and Choi, 1987; Chan et al., 2013). Despite efforts 
to develop a protocol to measure the amount of LDH release from acute hippocampal slices, my 
results indicate that following 10 minutes of OGD and a 3 hour recovery period, an increase in 
LDH release could not be detected when compared to SHAM slices. More specifically, the 
results violated an a priori condition, whereby no appreciable rise in LDH levels was shown in 
slices following an OGD challenge relative to SHAM slices. In an attempt to interpret these 
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unexpected results, I examined the experimental methods employed in this study, and was left 
with three possible explanations. 
Time of Assessment 
Failure to detect significant changes in LDH release may have been caused by the time at 
which slices were assessed after injury. My study used an acute ex vivo preparation of 
hippocampal slices in order to identify changes in cell viability across the longitudinal axis 
following OGD. In the context of neuronal insult, the brain slice model is advantageous as it 
maintains tissue architecture and synaptic circuitry; however, these studies are often restricted in 
their assessment of response to injury because slices can only remain functional for several hours 
before tissue degeneration (Cho et al., 2007; Mielke et al., 2007; Lien et al., 2011). As a result, 
outcome from excitotoxic damage is representative of the sort of acute cell death that would take 
place in the ischemic core (Taubenfeld et al., 2002; Cho et al., 2007; Lien et al., 2011) In 
contrast, in vitro cell culture models can be maintained for weeks to months, and allow for the 
detection of delayed cellular events that take place after brain injury (Cho et al., 2007). Although 
permeabilization of the cell membrane occurs during necrotic cell death, LDH-release from the 
cytoplasm appears to occur several hours to days after injury, which makes the assay more 
suitable for cell culture work (Vornov et al., 1991; Romano et al., 1995; Izumi et al., 2001). 
Clinical studies reported by Lampl et al. (1990) are also in agreement with these observations, 
whereby LDH activity detected in the CSF of men and women is greatest 48-120 hours 
following a cerebrovascular accident. The use of acute hippocampal slices in this study limited 
us to assaying LDH release just 3 hours following a 10 minute OGD challenge. Based on the 
delayed release of LDH following insult, my results would suggest that analyzing cell damage at 
this time point is too early to detect any significant effects of OGD on LDH release. Moreover, 
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the variations in LDH efflux observed between SHAM and OGD slices may be characteristic of 
normal fluctuations in basal levels of LDH released from cells at any given time.  
Model of Ischemic Injury 
 To induce brain injury, this study employed an ex vivo model of ischemia, OGD; for 
over a decade OGD has been used in numerous experiments involving neuronal insult and 
neuroprotection, and has been deemed a reliable stroke model (Tasca et al., 2015). While the 
general protocol for OGD (outlined in the materials and methods section 3.3) is usually similar, 
the duration of OGD may vary between studies, thereby leading to differences in the degree of 
damage sustained by slices (Tasca et al., 2015). Our study challenged septal and temporal 
hippocampal slices to 10 minutes of OGD followed by a 3 hour period of recovery; however, 
based on the results, this level of insult may not have been sufficient to cause changes in LDH 
release past basal levels. In support of this notion, work by Fernández-López et al. (2005) 
revealed that the amount of LDH release in forebrain slices was correlated with the length of the 
ischemic challenge. While 10 minutes of OGD caused an indistinguishable change in LDH 
release compared to control slices, LDH efflux was significantly increased following 30 minutes 
of OGD and a 3 hour recovery period (Fernández-López et al., 2005). Similarly, Pérez-
Rodríguez et al. (2015) uncovered enhanced LDH activity after 30 minutes of OGD and 3 hours 
of reperfusion, when compared to slices held at normoxic conditions. In an attempt to replicate 
these findings, a set of male hippocampal slices was exposed to 30 minutes of OGD; however, 
following a 3 hour period of recovery, a rise in LDH efflux was not detected. These results 
suggest that the length of injury may not be the only important factor to consider when modelling 
ischemic injury.     
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 Several studies, in which cell viability was quantified through LDH activity, have also 
displayed modifications to the traditional OGD protocol (Izumi et al., 2001; Siqueira et al., 2004; 
Zhou and Baudry, 2006; Mozes et al., 2012). For instance, Zhou and Baudry (2006) performed 
an ischemic challenge by placing hippocampal slices in vials containing 2 mL of aglycaemic 
ACSF that were previously gassed with N2 for 20 minutes. Following a 1 hour incubation length, 
LDH efflux was measured in the OGD medium and slices were transferred to vials containing 2 
mL of ACSF (saturated with carbogen) for a 2 hour reperfusion period. Following recovery a 
second measure of LDH was taken, and total LDH release was calculated as the sum of LDH 
efflux from the 1 and 2 hour incubation lengths (Zhou and Baudry, 2006). This experiment 
differed from the design of my study in two major ways: first, while acute slices were exposed to 
10 minutes of OGD in my study, the authors used a 1 hour length of OGD. Second, while my 
experiment maintained slices at interface, their study subjected hippocampal tissue to submerged 
conditions, which has been shown to cause a decrease in metabolic activity and synaptic function 
(Aitken et al., 1995; Ivanov and Zilberter, 2011). Thus, in addition to the insult endured during 
OGD, LDH release may have been influenced by cellular damage experienced during the 
recovery period, wherein, levels of oxygen may not have been sufficient to sustain the metabolic 
needs of slices (Ivanov and Zilberter, 2011).  
 The experimental design implemented by Zhou and Baudry (2006) did, however, raise 
the question of whether slices subjected to OGD under submerged conditions would release a 
greater amount of LDH compared to those held at interface. To answer this question, a set of 
hippocampal slices were placed in a vial containing 1 mL of aglycaemic ACSF, previously 
saturated with N2, for a 10 minute OGD challenge. A second set of slices were challenged with 
10 minutes of OGD using the standard interface approach (materials and methods section 3.3), 
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and, following OGD, LDH release was quantified in both submerged and interface groups. Slices 
from each condition were then maintained at interface for a 3 hour recovery period, and a second 
measure of LDH was taken thereafter; total LDH release was calculated as a sum of the two 
measures. Despite this modification, no appreciable rise in LDH efflux was observed in slices 
submerged during OGD, compared to SHAM slices, or slices held at interface during the OGD 
challenge (data not presented). Although these experiments were conducted on slices from 8-9 
month old female rats, as opposed to those from younger male rats, these findings indicate that 
with the method of brain slice preparation and maintenance used in my study, a significant 
increase in the level of LDH release cannot be observed following 10 minutes of OGD and a 3 
hour period of recovery.  
Additional Required Methods 
In addition to the induction of OGD, it is possible that the concurrent application of toxic 
agents may be required in order to promote the release of LDH from acute slices. This idea was 
demonstrated in a study by Mozes et al. (2012) wherein hippocampal slices subject to 1 hour of 
OGD did not release significantly higher amounts of LDH compared to control slices. In 
contrast, when slices were treated with beta-amyloid (Aβ 1-42) peptide, a toxin involved in 
Alzheimer’s disease, for 4 hours following OGD, a significant increase in LDH efflux was 
observed (Mozes et al., 2012). Treatment with other toxic reagents, including H2O2 and KCN 
following a 1 hour period of OGD also lead to enhanced LDH release (Mozes et al., 2012).  
 LDH is an intracellular enzyme commonly known to reside within the cell’s cytoplasm; 
however, a large proportion of LDH molecules are also attached directly to the cell membrane 
(Muronetz et al., 1996; Izumi et al., 2001). The presence of membrane-bound LDH may prevent 
its release into the extracellular environment, despite a neuronal insult. As such, some 
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researchers have accompanied their model of injury with additional methods that target 
degradation of the cell membrane, in order to encourage the release of membrane-bound LDH 
(Izumi et al., 2001).  In attempts to promote structural deterioration and LDH discharge, Izumi et 
al. (2001) employed a method of brief mild sonication with septal slices of the rat hippocampus. 
Tissue slices submerged in ACSF were subject to mild sonication pulses at two-second intervals 
following the administration of a toxin known as iodoacetate (IA). While exposure to the 
neurotoxin, or sonication alone did not cause significant changes in LDH activity, 20 pulses of 
mild sonication and 200 μM of  IA lead to a considerable release of cytosolic LDH (Izumi et al., 
2001).  
While the aforementioned study did not examine neuronal damage caused by ischemic 
insult, if their hypothesis holds true, my failure to detect a significant increase in LDH levels 
following OGD may be explained by its association with the cell membrane. While OGD 
indirectly influences cell membrane permeability through initiation of the ischemic cascade 
(Tasca et al., 2015), this method of insult may not be robust enough to disrupt the connection 
between LDH and the cell membrane. Although liberation of membrane-bound LDH is achieved 
through sonication, this method is more invasive and caution must be taken with its use, as 
excessive application can completely lyse the cell membrane and damage slices beyond the 
extent intended (Ashush et al., 2000). In addition, while exposure to neurotoxic agents may assist 
in membrane deterioration and LDH release, their effects may not directly reflect the 
pathophysiology of ischemia. Therefore, in attempts to preserve a clinically relevant model of 
ischemic injury, employing sonication, or additional toxic agents to hippocampal slices exposed 
to 10 minutes of OGD would not seem to be suitable methods. 
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5.2 2,3,5-Triphenyltetrazolium Chloride (TTC) Assay and Response to OGD  
5.2.1 Response to 10 Minutes of OGD did not differ across the Longitudinal Axis  
Ten minutes of OGD successfully caused ischemic injury in slices from across the 
longitudinal axis, indicated by significant reductions in TTC metabolism relative to SHAM 
slices. When comparing changes in TTC metabolism between the septal and temporal poles, 
however, no differences were observed. My results conflict with previous evidence, which 
suggests that differences in response to injury follow a septo-temporal gradient (Smith et al., 
1984; Ashton et al., 1989; Akai and Yanagihara, 1993; Rami et al., 1997; Papatheodoropoulos et 
al., 2005; Maggio et al., 2015). When male rats were subjected to transient forebrain ischemia, 
Rami et al. (1997) found that 82% of CA1 hippocampal neurons within the septal region 
displayed necrotic damage, but necrosis was only present in 16% of neurons from the temporal 
region; this is in contrast to the present study, where male and female pre-adolescent and post-
adolescent rats only showed a 5-10% difference in mitochondrial function between their septal 
and temporal poles. Although 10 minutes of OGD did not provoke changes in viability across the 
longitudinal axis as expected, these unanticipated findings may be explained by two possibilities.  
First, it is important to consider how cellular response to excitotoxic insult was measured 
in the various studies reported. Much of the work that has identified septo-temporal differences 
across the hippocampus used electrophysiological recordings to examine synaptic transmission 
(Ashton et al., 1989; Papatheodoropoulos et al., 2005; Maggio et al., 2015). Conversely, the 
present study utilized the TTC assay, which offers high-throughput screening of slice viability 
through quantifying mitochondrial activity (Watson et al., 1994). Given the differences in 
methods of quantification, failure to observe changes in response to ischemic damage between 
septal and temporal slices may be a reflection of the cellular change analyzed. 
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 Evoked field potentials and mitochondrial function were previously shown to be 
correlated measures of cell viability following OGD in acute hippocampal slices (Mielke et al., 
2007); however, this previous report did not account for potential differences between the septal 
and temporal poles. It is possible that this correlation may not exist across the longitudinal axis, 
and, while the modulation of synaptic transmission in response to brain injury appears to follow 
a septo-temporal gradient, changes in mitochondrial metabolism may not. To address this notion, 
it is worth considering the time at which cell viability was assessed. Viability measures were 
conducted 3 hours after the induction of OGD; therefore, changes in TTC metabolism would 
likely indicate an immediate reduction in mitochondrial function, rather than complete 
mitochondrial dysfunction, which is characteristic of delayed neuronal cell death (Elmore et al., 
2007). As such, it is possible that while both poles initially react equally to this assessment of 
damage, over time as downstream biological mechanisms take place, these discrepancies may 
become more pronounced.  
As previously discussed (literature review section 1.2), glutamate-mediated excitoxic 
damage can be explained through the “calcium-overload” hypothesis, where an initial rise in 
intracellular Ca2+-ions following cellular stress will trigger the mitochondria to store calcium 
within its matrices; a process known as calcium sequestration (Hossmann et al., 1985; 
Szydlowska and Tymianski., 2010). During ischemic insult, excessive accumulation of Ca2+-ions 
within mitochondria has been shown to cause damage to CA1 neurons, and this damage is 
further amplified by a second increase in calcium conductance following reperfusion, 
consequently leading to calcium over-load (Hossmann et al., 1985). Previous work has shown 
that calcium sequestration is capable of causing changes to mitochondrial metabolism within 
neurons, in areas of irreparable damage (Borgers et al., 1981; Simon et al., 1984), most likely 
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representative of the ischemic core. However, differences in response to mitochondrial injury 
may not be observed between areas of varying levels of sensitivity because it is thought that 
early signalling cascades following ischemia are similar between brain regions (Hossmann et al., 
1985). If this hypothesis holds true, then the failure to observe septo-temporal differences in 
mitochondrial function following 10 minutes of OGD and 3 hours of recovery  may be explained 
by the fact that viability was assessed during the acute phase of injury, when cell death pathways 
are thought to be analogous throughout the hippocampus. However, if a second measure of 
outcome was assessed that was not directly reflective of mitochondrial damage, such as 
electrophysiological or biochemical analyses, differences may become apparent across the 
longitudinal axis.  
A second reason that may explain these findings is that, while differences in response to 
neuronal damage exist along the hippocampal axis, they were not observed because of a high 
signal to noise ratio. The majority of studies that examined anatomical disparities across the 
hippocampus focused on susceptibility to injury within particular subfields of the septal and 
temporal poles (Ashton et al., 1988; Akai and Yanagihara, 1993; Rami et al., 1997; 
Papatheodoropoulos et al., 2005; Maggio et al., 2015). Previous evidence suggests that while the 
CA1 hippocampus displays the greatest sensitivity toward cellular stress, the DG displays the 
most tolerance (Schmidt-Kaster and Hossman, 1988). Consistent with this notion, it was reported 
that following experimental stroke, approximately 50-60% of slices failed to undergo synaptic 
transmission within the septal CA1; however only 2 of 120 slices failed to do so within the septal 
DG (Ashton et al., 1989). Histopathological changes also indicated that the septal CA1 subfield 
displayed greater vulnerability to ischemic insult than both the septal DG and the temporal CA1 
(Ashton et al., 1989). Similarly, Akai and Yanagihara (1993) reported that susceptibility to brain 
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ischemia was larger in the “subiculum CA1” region of the septal hippocampus, as compared to 
the CA3 region.  
 In this study, TTC metabolism following 10 minutes of OGD was measured in whole 
hippocampal slices, rather than within the individual subfields, across the longitudinal axis. 
However, as noted, given the selective vulnerability that exists between hippocampal subfields, 
potential septo-temporal differences may not have been detected because of varying degrees of 
ischemic tolerance within slices. While the septal CA1 appears to possess greater susceptibility 
to injury than the temporal CA1, the DG does not share this same pattern of vulnerability across 
the axis (Ashton et al., 1989). Therefore, the increased sensitivity of particular subfields to 
neurotoxicity, such as the CA1, may go unnoticed because of signals from regions more resilient 
to damage, such as the DG. As a result, potential differences in response to OGD would be 
masked by an overall equal level of TTC metabolism between septal and temporal poles. To 
address this discrepancy, in the future, the various subfields (CA1, CA3, and DG) should be 
micro-dissected and analyzed separately, in order to probe for differences in TTC metabolism 
across the longitudinal axis.  
5.2.2 Sex-Linked Differences Exist within the Septal Hippocampus of Pre-adolescent Rats in 
Response to 10 minutes of OGD  
 
Based on a broad range of literature, it has become widely accepted that response to 
ischemic injury exhibits sexual dimorphism (Alkayed et al., 1998; Du et al., 2004; Li et al., 2005; 
Liu et al., 2009; Cheng and Hurn, 2010; Manwani and McCullough, 2011). However, many of 
these differences are often explained by the presence of the primary sex hormones, estrogen and 
testosterone (Alkayed et al., 1998, 2001; Uchida et al., 2009; Brann et al., 2012; Fairbanks et al., 
2012), with less consideration given to the innate differences that may exist between male and 
female brain tissue (Arnold et al., 2003; Du et al., 2004; Cheng and Hurn, 2010).  To establish 
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the presence, and underlying cause, of sex-linked differences in response to OGD across the 
longitudinal axis, this research examined male and female rats at two distinct points of life. First, 
to assess the possible role of intrinsic sex differences, male and female litter-mates were taken at 
PND 26-29, which represented a period of pre-adolescence. Animals at this age are presumed to 
contain low, and equal, levels of sex hormones; therefore any differences in response to brain 
injury would be thought to reflect chromosomal, or molecular–based differences between sexes 
(Turtzo and McCullough, 2010).     
The results from this study indicated that hippocampal slices harvested from the septal 
pole of pre-adolescent male rats displayed greater sensitivity to 10 minutes of OGD when 
compared to their pre-adolescent female counterparts.  These findings are in agreement with 
previous in vitro studies which examined differences in response to neuronal injury in sex-
specific cell culture models (Du et al. 2004; Li et al., 2005; Hurn, 2014).  Li et al. (2005) found 
that organotypic hippocampal slice cultures derived from male pups at PND 7 sustained greater 
damage from exposure to OGD than female cultures. Similarly, in primary cultured hippocampal 
neurons, as well as in astrocytes and microvascular endothelial cell culture models, XY cells 
displayed increased susceptibility to OGD when compared to XX cells (Du et al., 2004; Heyer et 
al., 2005; Hurn, 2014). Results from my study are also representative of the disparities regarding 
brain injury that are observed clinically between male and female patients. While pre-adolescent 
boys are at a greater risk of developing neural disorders, such as cerebral palsy, pre-adolescent 
girls experience better functional outcome following traumatic brain injury (Donders and 
Hoffman, 2002; Vannucci and Hurn, 2009; Cikla et al., 2015). Although the reason for this 
sexual dimorphism is incompletely understood, the fact that these sex differences are observed 
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before the onset of puberty, in both laboratory and clinical settings, suggests that hormone-
independent mechanisms may influence response to ischemic injury.  
The notion of sex-specific molecular pathways following cellular damage was previously 
described by Du et al. (2004) whereby XX and XY neurons showed varying degrees of 
susceptibility and underwent distinct cell death pathways upon exposure to cytotoxic chemicals. 
To support the concept of sexually dimorphic cell death mechanisms, emerging evidence now 
suggests that while female brain tissue undergoes a caspase-dependent pathway, male brain 
tissue undergoes a caspase-independent pathway following ischemic insult (Lang and 
McCullough, 2008; Yuan et al., 2009; Turtzo and McCullough, 2010).  
 Caspases are a family of enzymes that perform cysteine protease activity and regulate 
cell death through the initiation of apoptosis (McIlwain et al., 2013). In general, apoptosis is 
regarded as a form of programmed cell death, whereby intracellular components are 
disassembled and condensed before being phagocytosed (Elmore, 2007). Within female neurons, 
the ischemic-induced shift in energy metabolism is thought to trigger a release of cytochrome c 
from the intramembrane space of the mitochondria (Du et al., 2004; Turtzo and McCullough, 
2010; McIlwain et al., 2013). Cytochrome c then binds to an adaptor protein known as apoptotic 
protease-activating factor-1 (APAF1), which leads to a number of conformational changes in its 
domain. Following these structural modifications, caspase-9 is bound and activated; resulting in 
the formation of a complex known as the apoptosome (Cain et al., 2002; Ferraro et al., 2009; 
McIlwain et al., 2013). With assembly of the apoptosome, downstream effector caspases are 
eventually recruited and apoptotic cell death is stimulated (Shiozaki et al., 2002; McIlwain et al., 
2013). 
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In contrast to the caspase-dependent pathway, the male-associated caspase-independent 
pathway appears to be triggered when activation of neuronal nitric oxide synthase (nNOS) leads 
to the over production of nitric oxide (NO) (Du et al., 2004; Li et al., 2005; Yuan et al., 2009). 
Excess intracellular levels of NO results in the generation of peroxynitrite (ONOO⁻), which 
subsequently leads to breaks in the strands of DNA (Hurn et al., 2005; Li et al., 2005; Yuan et 
al., 2009). In attempts to restore chromatin integrity, the DNA repair enzyme poly adenosine 
diphosphate ribose polymerase-1 (PARP-1) is activated (Li et al., 2005).  Under normal 
physiological conditions, PARP-1 utilizes the cell’s energy stores to repair single stranded DNA 
breaks; however during ischemia, PARP-1 becomes over stimulated and diminishes NAD+ and 
ATP levels, which leads to a microglia-induced inflammatory response that ultimately results in 
necrotic cell death (Hagberg et al., 2004; Sairanen et al., 2009).  
 Based on these distinct molecular pathways, the results from this study may be explained 
by differences in the form of cell death experienced by male and female brain tissue. While 
female neurons are shown to display an apoptotic method of cell death; neurons derived from 
male tissue undergo a more necrotic pathway (Lang and McCullough, 2008; Yuan et al., 2009; 
Turtzo and McCullough, 2010). In general, necrosis is an uncontrolled process, resulting from a 
loss of energy, and is characterized by cellular swelling and rupture of the cell membrane. 
Following membrane deterioration, the release of cytoplasmic components signals an 
inflammatory response, which often damages a large portion of adjacent cells (Trump et al., 
1997). In contrast, as previously mentioned, apoptosis is regarded as a more controlled 
mechanism that allows damaged cells to be removed without harming neighbouring cells, or 
causing inflammation (Elmore, 2007). As a result, the progression of apoptotic cell death is 
much slower than its counterpart, necrosis (Elmore, 2007). 
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 Much of the literature reporting biological sex differences following neuronal injury 
utilized cell culture systems (Du et al., 2004, Li et al., 2005; Yuan et al., 2009). While culture 
models are able to maintain viability over an extended length of time, which aids in the 
assessment of long term cellular damage, they generally use cells from late stage embryos, or 
neonates (Cho et al., 2007). In contrast, the acute hippocampal slice model is beneficial in 
examining animals at different stages of life. However, due to the limited lifespan of slices, only 
short term/immediate cellular processes are able to be analyzed (Cho et al., 2007). In this study, 
acute hippocampal slices were subject to 10 minutes of OGD, followed by a 3 hour period of 
recovery. Since cellular viability was assessed a short time after injury, changes in mitochondrial 
function would be more likely to reflect necrotic cell death, rather than apoptotic cell death. In 
considering this notion, it is possible that the observed increased sensitivity of pre-adolescent 
male septal slices to the effects of OGD was caused by increased vulnerability to necrosis. If the 
slice model allowed one to examine the effects of delayed cell death pathways involving 
apoptosis, it is possible that TTC metabolism in female slices would have been altered. 
Nonetheless, my findings suggest that the male septal hippocampus from pre-adolescent rats 
contains heightened sensitivity to OGD-mediated necrotic cell death pathways, when compared 
to similar tissue from female animals.   
Data from this study also displayed an apparent effect of sex within the temporal pole of 
pre-adolescent rodents; specifically, female temporal slices responded less well to 10 minutes of 
OGD than male temporal slices. This finding is opposite to the above mentioned results, in 
which male pre-adolescent tissue showed higher vulnerability to ischemic injury than female 
tissue within the septal pole. In addition, these results contradict evidence that reports greater 
ischemic tolerance within female neurons as compared to male neurons (Du et al., 2004).   
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 Further analysis of this data revealed that the p value was 0.07, indicating no statistical 
significance. P values are important in testing the probability that the observed difference 
between two experimental groups occurred by chance; values of 0.05 or less are interpreted as 
reflecting true differences, and are regarded as statistically significant (McGough and Faraone, 
2009). However, these calculations do not provide information on the clinical relevance, or the 
magnitude of effect that the differences between the groups display; therefore, in order to better 
understand the biological significance of the findings, Cohen’s d effect sizes were also calculated 
(McGough and Faraone, 2009). Although the calculated p value suggested no statistical 
significance, given that p = 0.07 is quite close to the conventional threshold of  p = 0.05, and, 
that a large effect size was obtained, it is worth considering the idea that pre-adolescent female 
temporal slices respond worse to ischemic insult than pre-adolescent male temporal slices. While 
the exact mechanism behind this phenomenon is currently unknown, it is possible that 
biochemical differences may exist between the temporal tissue of pre-adolescent male and 
female animals, which cause female slices to experience greater sensitivity toward 10 minutes of 
OGD. Further work examining differences in the expression of acute cell death markers, 
including SBDPs, should be completed in order to address this issue.  
5.2.3 Hormone-Dependent Sex-Linked Differences were not present between Post-adolescent 
Male and Female Rats across the Longitudinal Axis 
 
Apart from innate differences that exist between male and female brain tissue, a large 
body of literature also supports the claim that the primary sex hormones, estrogen and 
testosterone, play an intrinsic role in outcome from brain injury (Brann et al., 2007; Liu et al., 
2009). More specifically, the influence of estrogen on response to cellular stress has been heavily 
studied, although findings are often contradictory (see literature review section 1.4.3 and 1.4.4). 
In an attempt to better understanding the effects of sex hormones on response to ischemic insult, 
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sexually mature male and female rats at PND 60-64 (post-adolescence) were assessed. Results 
from this study indicated that TTC metabolism following 10 minutes of OGD and a 3 hour 
period of recovery did not differ between post-adolescent male and female animals across the 
longitudinal axis of the hippocampus. Given the number of studies reporting an “ischemia 
sensitive” phenotype in male brain and an “ischemia protective” phenotype within female brain 
during young adulthood, these results were fairly unexpected (Liu et al., 2009; Cheng and Hurn, 
2010; Manwani and McCullough, 2011).  
In an effort to explain these findings, we considered potential discrepancies that may 
have been present within post-adolescent female rodents, specifically with regards to fluctuating 
levels of estrogen. Throughout the 4 day rodent estrus cycle, concentrations of endogenous 
estrogen can range between 30 pg/mL (metestrus) to 140 pg/mL (proestrus) (Carswell et al., 
2000); therefore, a failure to observe hormone-dependent sex differences between male and 
female rats may have been caused by a high amount of noise from combining data from animals 
at different stages of the estrus cycle. Work by Carswell et al. (1999, 2000) demonstrated that, in 
sexually mature stroke prone spontaneously hypertensive rats, stratifying females based on their 
estrus cycle stage resulted in different outcomes from ischemic injury when compared to female 
rats that were not staged. When the estrus cycle was not controlled for, female rats displayed an 
infarct volume of 13%, 24 hours after MCAO; however, female rats determined to be in 
metestrus (low estrogen) showed an infarct volume of 30% in the contralateral hemisphere 
(Carswell et al., 1999). In addition, while the uncontrolled female group appeared to recover 
better from stroke when compared to male rodents, females in metestrus displayed a worse 
outcome than their male counterparts (Carswell et al., 1999).   
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In my study, stratifying post-adolescent female rats into high estrogen (proestrus) and 
low estrogen (estrus, metestrus and diestrus) groups did not yield appreciable differences in TTC 
metabolism following OGD within tissue from either the septal, or the temporal poles. This 
result is in contrast to evidence which found that rats with higher circulating levels of estrogen, 
in proestrus, displayed improved outcome from ischemia in vivo when compared to rats in low 
estrogen stages, such as metestrus and diestrus (Carswell et al., 2000; Raval et al., 2009). My 
findings are more in line, however, with research studying cardiac ischemia in isolated rodent 
hearts (Frasier et al., 2013; Hatcher et al. 2013). Hatcher et al. (2013) found that susceptibility to 
ischemic ventricular fibrillation (VF) did not differ between hearts isolated from female rodents 
at various stages of the estrus cycle. Similarly, differences in infarct volume following cardiac 
ischemic insult were not apparent between the four stages of the estrus cycle, in female rat hearts 
prepared ex vivo (Frasier et al., 2013).  
When analyzing studies where fluctuating levels of estrogen were shown to influence 
response to injury, and, comparing them to studies that did not observe the effects of sex 
hormones, differences in the experimental design must be taken into consideration. While the 
present study, as well as others that reported no influence of the estrus cycle, used an ex vivo 
model to induce ischemic injury (Frasier et al., 2013; Hatcher et al., 2013), studies where 
estrogen levels were shown to have an effect on outcome employed in vivo models of ischemia 
(Carswell et al., 1999, 2000; Raval et al., 2009).  Therefore, our failure to observe a hormone-
dependent effect on response to OGD may have been caused by a lack of circulating endogenous 
estrogen at distant sites of injury within the brain. In support of this claim, a review by Brann et 
al. (2007) highlighted that gonadal-derived estrogen played a significant role in protecting 
neurons against ischemic injury.  
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While many cellular pathways are thought to be involved in estrogen-mediated 
neuroprotection, in general it is thought that estrogen released from the ovaries travels through 
the circulatory system and activates mitogen activated protein kinase (MAPK) as well as 
calcium-calmodulin-dependent protein kinase (CAMKII) (Raval et al., 2009). MAPK and 
CAMKII go on to activate cyclic-AMP response element binding protein (CREB) through 
phosphorylation, which then initiates a downstream signalling cascade (Raval et al., 2009). 
Within the hippocampal CA1 subfield, following in vivo stroke, the phosphorylation of MAPK 
increased by 56% and phosphorylation of CAMKII increased by 71% during the shift from 
diestrus (low estrogen) to proestrus (high estrogen) (Raval et al., 2009). These findings 
corresponded with a reduction in the number of healthy neurons by 82% within diestrus animals, 
but a 17% increase in the number of healthy neurons within proestrus animals, 7 days post-injury 
(Raval et al., 2009). Taken together, these data support the notion that higher circulating levels of 
endogenous estrogen serve to protect against ischemic damage via phosphorylation of CREB 
within the intact animal (Raval et al., 2009). In light of this concept, the use of an acute 
hippocampal slice model would have prevented direct exposure of slices to the varying levels of 
estrogen in the bloodstream; therefore eliminating the activation of certain neuroprotective 
pathways. 
Apart from the effects of gonadal derived estrogen, a growing body of literature also 
suggests that estrogen can be produced in neurons within the hippocampal formation, following 
NMDA-mediated excitotoxicity, in order to exert neuroprotection (Hojo et al., 2004). Following 
MCAO, Carswell et al. (2005) observed an increase in the expression of aromatase, the enzyme 
critical for the production of estrogen, within the brain of OVX female rodents. In addition, 
McCullough et al. (2003) found that neuronal impairments after ischemic stroke were greater in 
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aromatase knock-out mice compared to OVX wild-type mice. Given that these studies indicated 
both the existence and the importance of locally synthesized estrogen on neuroprotection 
following brain injury, it was thought that extra-gonadal, brain-derived estrogen may have 
played a role in response to ischemic insult within acute hippocampal slices. Nonetheless, the 
failure to observe the effects of estrus cycle stage on 10 minutes of OGD in post-adolescent 
female brain slices may have been due to the time in which hippocampal tissue was assessed. As 
mentioned previously, response to OGD measured after a 3 hour period of reperfusion would be 
reflective of immediate damage within the ischemic core. However, it was reported that the 
upregulation of aromatase was only observed 8 hours and 24 hours after insult, and was not 
present 2 hours post-MCAO (Carswell et al., 2005). In addition, aromatase was predominantly 
expressed within the penumbra; therefore estrogen –facilitated neuronal protection would most 
likely be seen in areas of reversible damage rather than the ischemic core (Carswell et al., 2005).  
Together, these data suggest that the experimental design of this study would not allow for the 
observation of estrogen’s protective effects following OGD. If experimental stroke was induced 
in vivo, a longer period of reperfusion would have been permitted, which would allow for the 
induction of hormone-dependent genomic and non-genomic signalling pathways that are thought 
to be initiated following brain injury (Brann et al., 2007). Following a more delayed assessment, 
differences in cell viability from 10 minutes of OGD may have been observed between post-
adolescent male and female rats.   
5.2.4 Age-related Differences in TTC metabolism are present in the Male Septal Hippocampus 
Following 10 Minutes of OGD 
 
As previously noted, age was used in this study as a means to determine how naturally 
circulating levels of the primary sex hormones, estrogen and testosterone, might influence 
response to brain injury. In order to explore differences in mitochondrial function following 10 
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minutes of OGD, male and female rodents at ~PND 26, representing pre-adolescence, were 
compared to rodents at ~PND 60, representing young adulthood. Results from my study revealed 
no differences in TTC metabolism between pre-adolescent and post-adolescent female rats 
within the septal, or temporal poles of the hippocampus. Within male animals however, my data 
indicated that the septal hippocampus in pre-adolescent rats showed increased vulnerability to 
the effects of excitotoxicity when compared to their post-adolescent counterparts. Although rats 
at post-adolescence were considered adults, these animals do not represent an aged population 
and therefore would not have experienced the physiological changes that occur with advanced 
ageing, including reproductive senescence and the development of co-morbidities that often lead 
to poorer functional outcome after stroke (Manwani and McCullough, 2011). As such, the age-
related differences observed in response to neuronal injury may be more appropriately explained 
by the biological differences that exist between the immature and mature brain.      
The idea that the brain displays different levels of susceptibility to injury at various stages 
of development has been well established (Blomgren et al., 2003; Zhu et al., 2005; Giza et al., 
2009; Babikian et al., 2010; Semple et al., 2013). In this study, the use of rats at PND 26 
corresponded to the juvenile stage of brain maturation, spanning from the point of weaning 
(PND 21) to ~PND 45, whereas rats at PND 60 reflected the mature, adult brain (Semple et al., 
2013). Between these periods of life, several anatomical and molecular distinctions are thought 
to exist, which render the immature brain more susceptible to the effects of neuronal insult (Giza 
et al., 2009; Babikian et al 2010). One mechanism in particular pertains to the upregulation of 
mitochondrial defense systems following brain injury (Giza et al., 2009; Babikian et al., 2010; 
Semple et al., 2013). Cytotoxicity and oxidative stress result in excessive ROS generation within 
the cell. To control for this overproduction of ROS, mitochondrial antioxidant enzymes, 
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including superoxide dismutase (SOD) and glutathione peroxidase (GPx), are activated, and 
work to scavenge excess free radicals (Aspberg et al., 1992; Mavelli et al., 1982). Interestingly, 
work by Fan et al. (2003) found that this increase in antioxidant activity appeared to be an age-
related process. While the adult mouse brain expressed a 28% increase in GPx activity 3 hours 
after traumatic brain injury (TBI), there were no detectable changes in GPx activity present in 
mice at PND 21 (Fan et al., 2003). Furthermore, this failure to stimulate mitochondrial 
antioxidants corresponded to an increased susceptibility of the underdeveloped brain to neuronal 
damage (Fan et al., 2003). Taken together, it is possible that the worsened mitochondrial function 
observed in pre-adolescent male septal tissue, compared to post-adolescent male tissue, may 
have been related to an insufficient degree of antioxidant activity.   
A second potential factor that may have contributed to the age-related differences 
observed in response to ischemic challenge are changes in the NMDAR subunit composition, 
which occur during development (Monyer et al., 1994; Cull-Candy., 2001; Law et al., 2003; Giza 
et al., 2009; Semple et al., 2013). At birth, there is a dramatic rise in the expression of the GluN1 
receptor subunit, which peaks during the third week of life (Law et al., 2003). Conversely, while 
GluN2A subunit expression is low at birth, GluN2B expression is high, reaching maximal levels 
around PND 20 in the rat hippocampus and cortex (Giza et al., 2009; Semple et al., 2013). 
However, as the brain matures, the GluN2A:GluN2B ratio switches; while GluN2B subunits 
decline following the third/fourth week of life, they appear to be replaced with GluN2A subunits, 
and, less commonly, GluN2C subunits (Cull-Candy, 2001; Giza et al., 2009).  
The GluN2B subunit plays an essential part in excitatory neurotransmission following 
calcium influx (Lujan and Wan, 2012). During early stages of neuronal development, the 
increased expression of the GluN2B subunit is necessary for the induction of LTP, associated 
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with learning and memory; however, evidence also suggests that the GluN2B subunit is heavily 
involved in mediating excitotoxic cell death pathways leading to neurodegeneration (Giza et al., 
2009; Lujan and Wan, 2012). Based on the conflicting roles of the GluN2B subunit, it would 
appear that while its heightened expression allows for increased synaptic plasticity in the 
immature brain, it also renders young animals more susceptible to the effects of ischemic insult 
(Giza et al., 2009).  
 As previously described, changes in cellular viability observed 3 hours post-OGD would 
be associated with cell death pathways resulting in necrosis rather than delayed pathways leading 
to apoptosis (Czogalla and Sikorski, 2005). One of the earliest hallmarks of necrotic cell death is 
the excessive influx of Ca2+-ions, which trigger the activation of calcium-sensitive proteases 
known as calpains (Czogalla and Sikorski, 2005). In response to cellular stress calpains will 
undergo proteolytic activity in order to break down specific substrates associated with cellular 
maintenance (Czogalla and Sikorski, 2005; Yan and Jeromin, 2012). Spectrin (αII-spectrin), in 
particular, is a key component of the cytoskeleton that plays a role in the structural integrity and 
modulation of synaptic components (Yan and Jeromin, 2012).  Following neuronal injury, 
calpain will perform enzymatic cleavage of the 280 kDa αII-spectrin protein, creating 145 kDa 
and 150 kDa fragments, referred to as spectrin breakdown products (SBDPs) (Yan and Jeromin, 
2012). Both in vitro and in vivo models have provided evidence for the relation between 
excitotoxicity and calpain activation resulting in the appearance of SBDPs within the 
hippocampus (Yan and Jeromin, 2012). As such, SBDPs have now become a widely accepted 
biomarker of early necrotic cell death (Czogalla and Sikorski, 2005; Zhu et al., 2005; Yan and 
Jeromin, 2012).  
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 Differences in calpain-mediated necrotic cell death have been observed between the 
mature and immature brain following hypoxic-ischemic (HI) injury (Zhu et al., 2005). A study 
by Zhu et al. (2005) reported that while protein concentration of calpain remained consistent 
during the various stages of development, after HI there was an age-dependent decrease in 
calpain levels, indicative of increased activity and subsequent degeneration. Within the immature 
brain, male mice at PND 21 displayed a >20% loss in calpain levels; however, mice at PND 60 
revealed only a 5% reduction in calpain (Zhu et al., 2005).  These results suggest that immediate 
pathways of necrotic cell death may be more readily activated within the developing brain as 
compared to the adult brain. 
  Under pathophysiological conditions, there also appears to be a strong link between the 
over-activation of the NMDARs and the immediate presence of 145 kDa and 150 kDa SBDPs 
(Seubert et al., 1988; Siman et al., 1989; Delcerro et al., 1994; Bahr et al., 1995; Vanderklish et 
al., 1995; Wechsler and Teichberg, 1998; and Czogalla and Sikorski, 2005). Within cultured 
hippocampal neurons, SBDPs were apparent just 2 minutes after treatment with NMDA (Bahr et 
al., 1995); however, alternative measures of viability, including propidium iodide staining, could 
not be detected until 30 minutes later (Czogalla and Sikorski, 2005). Moreover, when exposed to 
NMDAR-antagonists, calpain-mediated SBDPs were not observed, thereby further supporting 
the relationship between NMDAR stimulation and calpain activity (DelCerro et al., 1994).  
 As mentioned earlier in this discussion, response to neuronal insult is thought to be, in 
part, regulated by the subunit composition of the NMDARs (Giza et al., 2009). In light of this 
notion, evidence suggests that following exposure to NMDA, calpain will selectively cleave the 
GluN2B subunit, creating 115 kDa fragments that remain active on the cell surface, and are 
assumed to be involved in post-ischemic excitotoxicity; a process that is not observed with the 
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GluN2A subunit (Simpkins et al., 2003). This calpain-mediated GluN2B cleavage was also 
associated with a greater number of SBDPs within the hippocampus of epileptic rats, as reported 
by Araujo et al. (2005). When taken together, these findings may help to explain the heightened 
sensitivity of pre-adolescent male tissue compared to the post-adolescent tissue that was 
observed in this study. If the immature brain contains a greater concentration of GluN2B 
NMDAR subunits, when compared to the mature brain, then tissue extracted from young animals 
would be more prone to calpain-mediated subunit cleavage than tissue extracted from adult 
animals. Consequently, this would leave pre-adolescent male septal slices more susceptible to 
mitochondrial impairments and exacerbated damage following 10 minutes of OGD, as compared 
to post-adolescent septal slices. 
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6.0 Conclusions and Future Directions 
 In the present study, both the age and sex of an animal appeared to have an influence on 
response to OGD, in a region of the brain previously reported to be selectively vulnerable to 
ischemic insult.  When taken together, these results suggest that the septal pole of pre-adolescent 
male rodents displays greater sensitivity to neuronal injury than both pre-adolescent female 
rodents, and post-adolescent male rodents. To explore potential differences in necrotic cell death 
pathways that may contribute to this increased vulnerability, calpain activity and SBDPs will be 
probed in each experimental group using Western blot analysis. In addition, the results from this 
study were not in agreement with previous literature, which found differences in response to 
injury across the longitudinal axis of the hippocampus. To further study these differences, acute 
hippocampal slices will be sub-dissected into their three main subfields (CA1, CA3 and DG) and 
response to OGD across the axis will be assessed accordingly. Finally, the use of an ex vivo 
system posed certain limitations with respect to the time of assessment, as well as not allowing 
for the examination of an intact animal model. In the future, the use of an in vivo system will be 
used in order to examine the effects of delayed cell death, as well as to further understand the 
role that endogenous hormones, such as estrogen, play on response to OGD across the 
hippocampal axis.  
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Region Age Sex N 
Temporal Pre-Adolescent6 Male 1 
Temporal Pre-Adolescent Female 2 
Temporal Post-Adolescent Male 3 
Temporal Post-Adolescent Female 3 
 
Table 1: Summary of data excluded from analysis. Male and female pre and post-adolescent 
animals excluded from the final data analysis based on TTC metabolism values that violated an a 
priori assumption.   
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Table 2: Statistical table for regional differences. Data presented as % of SHAM TTC 
metabolism. Relative mean difference scores (D.S.) ± standard error of the mean (SEM) 
calculated between septal and temporal slices in male and female pre and post-adolescent 
animals. Statistical significance represented by p value and Cohen’s d value ± 95% confidence 
interval (CI).    
 
 
 
 
 
 
 
 
 
 
 
 
 Mean % 
SHAM 
Septal 
Mean % 
SHAM 
Temporal 
D.S. SEM  N p 
Value 
Effect 
Size  
(d) 
± 95% 
CI 
Male  
Pre-
adolescent 
59.99 69.92 -10.00 6.0 9 0.20 0.55 
-1.24, 
0.17 
Female  
Pre-
adolescent  
73.88 62.92 10.96 8.8 10 0.43 0.39 
-0.26, 
1.03 
Male  
Post-
Adolescent  
71.54 62.49 9.05 6.1 10 0.19 0.47 
-0.2,  
1.1 
Female Post-
adolescent 
71.69 63.80 5.09 7.0 10 0.49 0.23 
-0.41, 
0.85 
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 Mean % 
SHAM 
Male  
Mean % 
SHAM 
Female 
D.S. SEM N p 
Value 
Effect 
Size 
(d) 
± 95% 
CI 
Septal 
Pre-
adolescent 
59.99 73.88 -13.16 4.89 9 0.04 0.90 
-1.66,   
 -0.10 
 
Temporal  
Pre-
adolescent  
69.92 62.92 10.86 4.06 9 0.07 0.89 
0.09, 
1.7 
Septal 
Post-
Adolescent  
71.54 71.69 -0.15 2.82 10 0.63 0.017 
-0.64, 
0.60 
Temporal 
Post-
adolescent 
62.49 63.80 -1.31 8.47 10 0.63 0.049 
-0.67, 
0.57 
 
Table 3: Statistical table for sex-linked differences. Data presented as % of SHAM TTC 
metabolism. Difference scores (D.S.) ± standard error of the mean (SEM) calculated between 
pre-adolescent, as well as post-adolescent, male and female animals in both the septal and 
temporal poles. Statistical significance represented by p value and Cohen’s d value ± 95% 
confidence interval (CI).    
     
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
  
 Mean % 
SHAM 
Pre-
Adolescent  
Mean % 
SHAM 
Post-
Adolescent  
D.S. SEM N p Value Effect 
Size 
(d) 
± 95% 
CI 
Male Septal 
59.99 71.54 -12.03 5.86 9 0.05 0.68 
-1.40, 
0.06 
Female 
Septal 
73.88 71.69 2.19 4.15 10 0.77 0.17 
-0.46, 
0.79 
Male 
Temporal 
69.92 62.49 5.80 7.4 9 0.57 0.26 
-0.41, 
0.92 
Female 
Temporal 
62.92 63.80 -0.88 9.14 10 0.85 0.03 
-0.65, 
0.59 
 
Table 4: Statistical table for age-related differences. Data presented as % of SHAM TTC 
metabolism. Difference scores (D.S.) ± standard error of the mean (SEM) calculated between 
pre-adolescent and post-adolescent male and female animals in both the septal and temporal 
poles. Statistical significance represented by p value and Cohen’s d value ± 95% confidence 
interval (CI).    
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 Mean % 
SHAM 
Septal 
Mean % 
SHAM 
Temporal 
N D.S. SEM p 
Value 
Effect 
Size  
(d) 
± 95% 
CI 
High 
Estrogen 
63.93 67.89 5 -3.96 14.73 > 0.99 0.12 
-0.99, 
0.77 
Low 
Estrogen  
72.12 65.07 8 7.06 7.07 0.313 0.35 
-0.79, 
0.61 
 
Table 5: Statistical table for estrogen levels and regional differences. Data presented as % of 
SHAM TTC metabolism. Difference scores (D.S.) ± standard error of the mean (SEM) 
calculated between septal and temporal slices from female animals in high estrogen, and low 
estrogen, groups. Statistical significance represented by p value and Cohen’s d value ± 95% 
confidence interval (CI).    
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 Mean % 
SHAM 
High E2 
SEM Mean % 
SHAM 
Low E2 
SEM p 
Value  
Effect Size 
(d) 
± 95% CI 
Septal 
63.93 5.01 72.12 3.52 0.35 0.78 -0.36, 1.93 
Temporal 
67.89 10.47 65.52 6.07 0.72 0.14 -0.98, 1.26 
 
Table 6: Statistical table for estrogen-concentration dependent differences. % of SHAM 
TTC metabolism ± standard error of the mean (SEM) compared between female rats from high 
and low estrogen groups in both the septal, and temporal, poles. Statistical significance 
represented by p value and Cohen’s d value ± 95% confidence interval (CI).    
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Pathophysiology of Ischemic Stroke 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Key cellular elements involved in the ischemic cascade.  
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(A) 
 
 
 
 
 
Figure 2: The longitudinal axis of the rat hippocampus. (A) The dorsoseptal and 
ventrotemporal poles of the rat longitudinal axis are outlined. The lines are indicative of the 
portion of tissue each region occupies; the septal pole extends across the first two-thirds of the 
hippocampal long axis, while the temporal pole occupies the remaining one-third of the 
hippocampus. Figure adapted from “Functional organization of the hippocampal longitudinal 
axis,” by B. A. Strange, M. P. Witter, E.S. Lein and E. I. Moser, 2014, Nature Reviews, vol 15, 
pp. 658. Copyright 2014 Macmillan Publishers. (B) Hippocampal slices prepared across the 
longitudinal axis. Figure adapted from “Anatomical and Electrophysiological Comparison of 
CA1 Pyramidal Neurons of the Rat and Mouse,” by B. N. Routh, D. Johnston, K. Harris and R. 
A. Chitwood, 2009, J Neurophysiol, vol 102, pp. 2291. Copyright 2009 The American 
Physiological Society.  
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Experimental Protocol 
Figure 3: Summary of experimental protocol. 
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Figure 4: Representative image of wet vaginal smear from each stage of the rat estrus cycle. 
200 x. Figure taken, with permission, from  “A quantitative method for assessing stages of the rat 
estrous cycle” by CH Hubscher et al.., 2005, Biotechnic and Histochemistry ,vol.80:2, pp.79-87,  
www.tandfonline.com http://dx.doi.org/10.1080/10520290500138422. 
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(A)                                                           (B) 
 
 
 
 
 
 
(C)                                                           (D) 
 
 
 
 
 
Figure 5: 10 minutes of OGD did not cause significant changes in LDH release in pre-
adolescent slices across the longitudinal axis. (A) Male septal slices (arbitrary units: SHAM, 
0.154  ± 0.02 vs. OGD, 0.133 ± 0.02) (B) Male temporal slices (arbitrary units: SHAM, 0.198  ± 
0.03 vs. OGD, 0.193 ± 0.03) (C) Female septal slices (arbitrary units: SHAM, 0.156 ± 0.02 vs. 
OGD, 0.128 ± 0.01) or (D) Female temporal slices (arbitrary units: SHAM, 0.23 ± 0.02 vs. OGD, 
0.19 ± 0.01); N = 5 litters with the average of 2 animals from each litter being used. Data are 
presented as mean ± SEM.  
 
 
 
 
♂, Septal ♂, Temporal 
♀, Septal ♀, Temporal 
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(A)                                              (B)   
 
 
 
 
 
 
(C)         (D)  
 
 
 
 
 
 
Figure 6: 10 minutes of OGD did not cause significant changes in LDH release in post-
adolescent slices. (A) Male septal slices (arbitrary units: SHAM, 0.216  ± 0.007 vs. OGD, 0.179 
± 0.01) (B) Male temporal slices (arbitrary units: SHAM, 0.237 ± 0.02 vs. OGD, 0.212 ± 0.01) 
(C) Female septal slices (arbitrary units: SHAM, 0.186 ± 0.01 vs. OGD, 0.162 ± 0.01) or (D) 
Female temporal slices (arbitrary units: SHAM, 0.238 ± 0.01 vs. OGD, 0.233 ± 0.01); N = 5 
litters with the average of 2 animals from each litter being used. Data are presented as mean ± 
SEM. 
♂, Septal ♂, Temporal 
♀, Septal ♀, Temporal 
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Figure 7: 30 Minutes of OGD did not cause significant changes in LDH release. Data 
presented as mean ± SEM. Percent change in LDH released from slices subjected to 30 min of 
OGD and a 3 h recovery (slices held at interface throughout) vs. slices kept in a glass vial with   
1 mL ACSF for 4 h at 35.0 ± 0.5oC (slices submerged; positive control). Slices harvested from 
pre-adolescent male rats.     
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(A) 
 
 
 
 
 
 
 
 
(B)  
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Ten minutes of OGD has a large effect on TTC metabolism. Ten minutes of OGD 
has a large effect on TTC metabolism relative to SHAM treatment in both (A) septal (arbitrary 
units: SHAM, 0.087 ± 0.01 vs. OGD, 0.063 ± 0.01; Cohen’s d = 2.01 (95% CI = 0.40, 3.54) and 
(B)  temporal slices (arbitrary units: SHAM, 0.19 ± 0.02 vs. OGD, 0.11 ± 0.02; Cohen’s d = 1.86 
(95% CI = 0.29, 3.35); n = 2 animals from each of N = 5 litters. All slices were harvested from 
male rats at ~PND 60. Data presented as mean ± SEM; *p = 0.03, **p = 0.0079 following the 
Mann-Whitney U test. Effect size calculated using Cohen’s d; # = large effect size.  
 
 
# 
# 
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Figure 9: TTC metabolism following 10 minutes of OGD does not differ across the 
longitudinal axis in male and female rats. Post-OGD TTC metabolism was not appreciably 
different between septal and temporal slices in pre-adolescent male [p = 0.2; Cohen’s d = 0.55 
(95% CI = -1.24, 0.17)];  n = 2 animals from each of N = 9 litters, pre-adolescent female            
[p = 0.43; Cohen’s d = 0.39 (95% CI = -0.26, 1.03)], post-adolescent male [p = 0.19; Cohen’s     
d = 0.47 (95% CI = -0.2, 1.11)], or post-adolescent female [p = 0.49; Cohen’s d = 0.23 (95%     
CI = -0.41, 0.85)] rats ; n = 2, N = 10. Data presented as mean difference score (D.S.) ± SEM. 
Statistical significance measured using the Wilcoxon signed-ranked test; p < 0.05. Effect size 
calculated using Cohen’s d.   
 
 
 
 
If D.S. = 0 the two poles react to injury 
in a similar manner. 
 
If D.S. < 0 the septal pole is more 
sensitive to injury. 
 
If D.S. > 0 the temporal pole is more 
sensitive to injury. 
77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Sex has a large effect on differences in TTC metabolism between pre-adolescent 
male and female rats. Ten minutes of OGD had a large effect on changes in TTC metabolism 
between pre-adolescent male and female septal [p = 0.039; Cohen’s d = 0.90 (95% CI= -1.66,     
-0.10)] and temporal [p = 0.07; Cohen’s d = 0.89 (95% CI = 0.09, 1.66)] slices; n = 2 animals 
from each of N = 9 litters. 10 minutes of OGD did not have a large effect on changes in TTC 
metabolism between post-adolescent male and female septal [p = 0.63; Cohen’s d = 0.02 (95% 
CI = -0.64, 0.60)] or temporal [p = 0.63; Cohen’s d = 0.05 (95% CI = -0.67, 0.57)] slices; n = 2, 
N = 10. Data are presented as mean difference score (D.S.) ± SEM. Statistical significance was 
measured using the Wilcoxon signed-ranked test; *p < 0.05. Effect size calculated using Cohen’s 
d; # = large effect size. 
 
 
 
 
 
  
If D.S. = 0 both sexes react to injury in 
a similar manner. 
 
If D.S. < 0 the male group is more 
sensitive to injury. 
 
If D.S. > 0 the female group is more 
sensitive to injury. 
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Figure 11: TTC metabolism following 10 minutes of OGD significantly differs between pre 
and post-adolescent male rats. TTC metabolism following 10 minutes of OGD was 
significantly different between pre-adolescent and post-adolescent male septal slices [p = 0.05; 
Cohen’s d = 0.68 (95% CI= -1.4, 0.06)]; n = 2 animals from each of N = 9 litters. TTC 
metabolism following 10 minutes of OGD did not appreciably differ between pre-adolescent and 
post-adolescent female septal slices [p = 0.77; Cohen’s d = 0.17 (95% CI= -0.46, 0.79)]; n = 2,  
N = 10, or between male  temporal [p = 0.57; Cohen’s d = 0.26 (95% CI =  -0.41, 0.92)]; n = 2, 
N = 9, or  female temporal slices [p = 0.85; Cohen’s d = -0.03 (95% CI =  -0.65, 0.59)]; n =2,    
N = 10. Data are presented as mean difference score (D.S.) ± SEM. Statistical significance was 
measured using the Wilcoxon signed-ranked test *p = 0.05. Effect size calculated using Cohen’s 
d. # = moderate effect size. 
 
 
 
If D.S. = 0 both age groups react to 
injury in a similar manner. 
 
If D.S. < 0 the pre-adolescent group is 
more sensitive to injury. 
 
If D.S. > 0 the post-adolescent group is 
more sensitive to injury. 
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Figure 12: Estrogen levels do not influence TTC metabolism following OGD across the 
longitudinal axis in sexually mature female rats. TTC metabolism following 10 minutes of 
OGD was not appreciably different between septal and temporal slices in high estrogen (E2)     
[p > 0.99; Cohen’s d = 0.12 (95% CI = -0.99, 0.77]; n = 2 slices from each of N = 5 animals, or 
low E2 [p = 0.31; Cohen’s d = 0.35 (95% CI= -0.79, 0.61)]; n = 2, N = 8, stages of the estrus 
cycle. Data are presented as mean difference score (D.S.) ± SEM. Statistical significance was 
measured using the Wilcoxon signed-ranked test; *p < 0.05. Effect size calculated using Cohen’s 
d. 
 
 
 
 
 
If D.S. = 0 the two poles react to 
injury in a similar manner. 
 
If D.S. < 0 the septal pole is more 
sensitive to injury. 
 
If D.S. > 0 the temporal pole is more 
sensitive to injury. 
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(A) 
(B) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Differences in estrogen levels do not influence TTC metabolism following OGD 
in sexually mature female rats. (A) TTC metabolism following 10 minutes of OGD was not 
appreciably different between septal slices from post-adolescent female rats with high (63.93 ± 
5.01; n = 2 slices from each of N = 5 animals), or low (72.12 ± 3.52; n = 2, N= 8) levels of 
circulating E2 [p = 0.35; Cohen’s d = 0.78 (95% CI = -0.36, 1.93)]. (B) TTC metabolism 
following 10 minutes of OGD was not appreciably different between temporal slices from post-
adolescent female rats with high (67.89 ± 10.47; n = 2 slices from each of N = 5 animals), or low 
(65.07 ± 6.07; n = 2, N= 8) levels of circulating E2 [p = 0.72; Cohen’s d = 0.14 (95% CI =         
-0.98, 1.3)]. Data are presented as mean ± SEM. Statistical significance was measured by Mann-
Whitney U test. 
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Figure 14: Standard curve protein loading characterization blot. Hippocampal homogenate 
ranging from 2.5 – 15 μg was loaded for αII-spectrin immunoblotting to determine the optimal 
protein loading concentration. The 5 μg of protein was determined to yield the best signal. 
Samples were taken from post-adolescent male septal SHAM tissue. SBDP, spectrin breakdown 
products. 
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Figure 15: Expression of SBDPs across the longitudinal axis following OGD.  Representative 
blot of 150 kDa SBDPs in septal and temporal slices treated under 10 minutes of SHAM, or 
OGD conditions. Samples taken from pre-adolescent male tissue.  
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